PDB ID: 1tbf

Macromolecule:
CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE

Source Organism:
Homo sapiens

Pfam Annotation:
PDEase_I

Ligand ID:
VIA

Drugbank ID:
Sildenafil (DB00203)

HETATM residue:
VIA A 501

No. of binding residues:16

Fragment sites:
1TBF_A_VIAA501_0 (10 residues)
1TBF_A_VIAA501_1 (6 residues)

Click the tab to get the list of similar binding patterns of amino acids

• All Fragments
• 1TBF_A_VIAA501_0
• 1TBF_A_VIAA501_1

List of all similar binding patterns of amino acids (All fragments)

Note that only 3-12 residue patterns can be used for ASSAM searches, thus the binding sites are divided into fragments. Hit pattern: 3D amino acid arrangements similar to known drug binding site Query pattern: Residues from known binding site for annotated drug that match the hit pattern (Click on the 'View' column to view superposed patterns of amino acids - Superposition on full binding site) (Click the 'Script' button to download a python script for molecular docking in UCSF Chimera)

	Hit	Macromolecule/ Organism	Pfam	Res.	Residue Matches	HETATM Residue/s	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5jo3	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	10	TYR B 612 - TYR A 612 HIS B 613 - HIS A 613 ALA B 779 - ALA A 779 VAL B 782 - VAL A 782 ALA B 783 - ALA A 783 PHE B 786 - PHE A 786 LEU B 804 - LEU A 804 ILE B 813 - ILE A 813 MET B 816 - MET A 816 GLN B 817 - GLN A 817	None ZN  B 901 ( 4.9A) 6LK  B 903 (-3.7A) 6LK  B 903 ( 4.9A) None None 6LK  B 903 (-4.0A) None 6LK  B 903 (-4.0A) 6LK  B 903 (-3.3A)	0.51A	54.3	99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1tbf	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	9	TYR A 612 - TYR A 612 HIS A 613 - HIS A 613 ALA A 779 - ALA A 779 VAL A 782 - VAL A 782 ALA A 783 - ALA A 783 PHE A 786 - PHE A 786 LEU A 804 - LEU A 804 ILE A 813 - ILE A 813 GLN A 817 - GLN A 817	None None VIA  A 501 (-4.6A) VIA  A 501 ( 4.6A) VIA  A 501 ( 3.9A) VIA  A 501 (-4.9A) VIA  A 501 (-4.4A) VIA  A 501 ( 4.6A) VIA  A 501 (-3.0A)	0.04A	57.9	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	7jsn	ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT BETA (Bos taurus)	GAF PDEase_I	7	TYR B 556 - TYR A 612 HIS B 557 - HIS A 613 ALA B 733 - ALA A 779 VAL B 736 - VAL A 782 ALA B 737 - ALA A 783 PHE B 740 - PHE A 786 GLN B 771 - GLN A 817	None None None VDN  B 904 ( 4.8A) VDN  B 904 ( 4.1A) None VDN  B 904 ( 3.0A)	0.50A	38.4	20.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1tbf	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	7	TYR A 612 - TYR A 612 HIS A 613 - HIS A 613 VAL A 782 - VAL A 782 PHE A 786 - PHE A 786 LEU A 804 - LEU A 804 MET A 816 - MET A 816 GLN A 817 - GLN A 817	None None VIA  A 501 ( 4.6A) VIA  A 501 (-4.9A) VIA  A 501 (-4.4A) VIA  A 501 ( 4.3A) VIA  A 501 (-3.0A)	0.61A	57.9	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5u00	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	6	TYR A 655 - TYR A 612 HIS A 656 - HIS A 613 ALA A 823 - ALA A 779 PHE A 830 - PHE A 786 ILE A 855 - ILE A 813 GLN A 859 - GLN A 817	None 7OV  A1001 (-4.0A) None 7OV  A1001 (-4.3A) None 7OV  A1001 (-3.1A)	0.40A	44.3	36.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6cyc	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	6	TYR A 655 - TYR A 612 HIS A 656 - HIS A 613 ALA A 823 - ALA A 779 PHE A 830 - PHE A 786 ILE A 855 - ILE A 813 GLN A 859 - GLN A 817	FKJ  A1003 (-4.7A) FKJ  A1003 (-4.6A) None EDO  A1005 ( 3.8A) None FKJ  A1003 (-3.0A)	0.47A	43.4	35.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	7jsn	ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA (Bos taurus)	GAF PDEase_I	6	TYR A 558 - TYR A 612 HIS A 559 - HIS A 613 ALA A 735 - ALA A 779 VAL A 738 - VAL A 782 ALA A 739 - ALA A 783 PHE A 742 - PHE A 786	None None None None VDN  A 904 ( 3.9A) None	0.51A	23.1	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1zkl	HIGH-AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A (Homo sapiens)	PDEase_I	6	TYR A 211 - TYR A 612 HIS A 212 - HIS A 613 VAL A 380 - VAL A 782 PHE A 384 - PHE A 786 ILE A 409 - ILE A 813 GLN A 413 - GLN A 817	IBM  A 503 (-4.6A) None IBM  A 503 (-4.7A) IBM  A 503 (-4.5A) None IBM  A 503 (-3.0A)	0.51A	38.5	29.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2r8q	CLASS I PHOSPHODIESTERASE PDEB1 (Leishmania major)	PDEase_I	6	TYR A 680 - TYR A 612 HIS A 681 - HIS A 613 ALA A 850 - ALA A 779 VAL A 853 - VAL A 782 PHE A 857 - PHE A 786 GLN A 887 - GLN A 817	IBM  A   3 ( 4.7A) IBM  A   3 ( 4.8A) None IBM  A   3 ( 4.8A) IBM  A   3 (-4.9A) IBM  A   3 (-3.3A)	0.51A	40.8	31.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6fe3	PHOSPHODIESTERASE (Trypanosoma brucei)	PDEase_I	6	TYR A 668 - TYR A 612 HIS A 669 - HIS A 613 ALA A 837 - ALA A 779 VAL A 840 - VAL A 782 PHE A 844 - PHE A 786 GLN A 874 - GLN A 817	None None D68  A1003 (-4.0A) D68  A1003 (-4.9A) D68  A1003 (-4.9A) D68  A1003 (-3.2A)	0.63A	39.9	31.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5h2q	PHOSPHODIESTERASE (Trypanosoma brucei brucei)	PDEase_I	5	TYR A 668 - TYR A 612 HIS A 669 - HIS A 613 ALA A 838 - ALA A 779 VAL A 841 - VAL A 782 PHE A 845 - PHE A 786	LLI  A1003 ( 4.9A) None LLI  A1003 ( 4.3A) LLI  A1003 (-4.6A) LLI  A1003 (-4.6A)	0.36A	40.9	33.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ecm	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	PDEase_I	5	TYR A 555 - TYR A 612 HIS A 556 - HIS A 613 ALA A 741 - ALA A 779 ILE A 774 - ILE A 813 GLN A 778 - GLN A 817	None	0.43A	38.4	27.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5h2q	PHOSPHODIESTERASE (Trypanosoma brucei brucei)	PDEase_I	5	TYR A 668 - TYR A 612 HIS A 669 - HIS A 613 ALA A 838 - ALA A 779 VAL A 841 - VAL A 782 GLN A 875 - GLN A 817	LLI  A1003 ( 4.9A) None LLI  A1003 ( 4.3A) LLI  A1003 (-4.6A) LLI  A1003 (-3.1A)	0.54A	40.9	33.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	7jsn	ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA (Bos taurus)	GAF PDEase_I	5	HIS A 559 - HIS A 613 ALA A 735 - ALA A 779 VAL A 738 - VAL A 782 ALA A 739 - ALA A 783 GLN A 773 - GLN A 817	None None None VDN  A 904 ( 3.9A) VDN  A 904 ( 3.3A)	0.59A	23.1	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3so6	LDL RECEPTOR ADAPTOR PROTEIN (Rattus norvegicus; synthetic construct)	PID	5	ALA A 163 - ALA A 779 VAL A 166 - VAL A 782 ALA A 167 - ALA A 783 PHE A 170 - PHE A 786 ILE A 112 - ILE A 813	None	0.62A	NA	20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1zkl	HIGH-AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A (Homo sapiens)	PDEase_I	5	HIS A 212 - HIS A 613 VAL A 380 - VAL A 782 PHE A 384 - PHE A 786 LEU A 401 - LEU A 804 GLN A 413 - GLN A 817	None IBM  A 503 (-4.7A) IBM  A 503 (-4.5A) None IBM  A 503 (-3.0A)	0.73A	38.5	29.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2dfa	HYPOTHETICAL UPF0271 PROTEIN TTHB195 (Thermus thermophilus)	LamB_YcsF	5	ALA A 229 - ALA A 779 VAL A 232 - VAL A 782 ALA A 233 - ALA A 783 LEU A 5 - LEU A 804 ILE A 24 - ILE A 813	None	0.94A	NA	20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4uej	GALACTITOL-1-PHOSPHATE 5-DEHYDROGENASE (Escherichia coli)	ADH_N ADH_zinc_N	5	ALA A 250 - ALA A 779 VAL A 247 - VAL A 782 ALA A 246 - ALA A 783 LEU A 258 - LEU A 804 ILE A 233 - ILE A 813	None	0.95A	NA	22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5oes	GLUTATHIONE SYNTHETASE (Solanum tuberosum)	GSH_synth_ATP GSH_synthase	5	ALA A 77 - ALA A 779 VAL A 80 - VAL A 782 ALA A 81 - ALA A 783 PHE A 84 - PHE A 786 LEU A 154 - LEU A 804	None	1.01A	NA	21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5oes	GLUTATHIONE SYNTHETASE (Solanum tuberosum)	GSH_synth_ATP GSH_synthase	5	VAL A 80 - VAL A 782 ALA A 81 - ALA A 783 PHE A 84 - PHE A 786 LEU A 154 - LEU A 804 ILE A 437 - ILE A 813	None	1.05A	NA	21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ft4	DNA (CYTOSINE-5)-METHYLTRANSFERASE 1 (Zea mays; synthetic construct)	BAH Chromo DNA_methylase	5	TYR B 597 - TYR A 612 ALA B 854 - ALA A 779 VAL B 857 - VAL A 782 ALA B 858 - ALA A 783 LEU B 557 - LEU A 804	None	1.18A	NA	18.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3k11	PUTATIVE GLYCOSYL HYDROLASE (Bacteroides thetaiotaomicron vpi-5482)	Glyco_hydro_88	5	TYR A 83 - TYR A 612 VAL A 137 - VAL A 782 ALA A 138 - ALA A 783 PHE A 141 - PHE A 786 ILE A 158 - ILE A 813	None	1.20A	NA	20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ocd	L-ASPARAGINASE I (Vibrio cholerae)	Asparaginase Asparaginase_C	5	VAL A 205 - VAL A 782 PHE A 105 - PHE A 786 LEU A 101 - LEU A 804 ILE A 208 - ILE A 813 GLN A 69 - GLN A 817	None	1.22A	NA	21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4i9f	GLYCEROL 3-PHOSPHATE PHOSPHATASE (Mycobacterium tuberculosis)	GNAT_like Hydrolase_6 Hydrolase_like	5	TYR A 240 - TYR A 612 ALA A 306 - ALA A 779 VAL A 239 - VAL A 782 ALA A 238 - ALA A 783 ILE A 250 - ILE A 813	None	1.23A	NA	20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6sfw	ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUBUNIT CLPX (Listeria monocytogenes)	AAA_2 ClpB_D2-small zf-C4_ClpX	5	TYR O 93 - TYR A 612 ALA O 88 - ALA A 779 VAL O 89 - VAL A 782 ALA O 86 - ALA A 783 LEU O 71 - LEU A 804	None	1.25A	NA	23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6pux	HOMOSERINE O-ACETYLTRANSFERASE (Mycobacterium tuberculosis (strain atcc 25618 / h37rv))	Abhydrolase_1	5	ALA A 97 - ALA A 779 VAL A 98 - VAL A 782 ALA A 99 - ALA A 783 LEU A 57 - LEU A 804 ILE A 66 - ILE A 813	None	1.25A	NA	22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3qan	1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE 1 (Bacillus halodurans)	Aldedh	5	VAL A 422 - VAL A 782 ALA A 423 - ALA A 783 PHE A 424 - PHE A 786 LEU A 337 - LEU A 804 MET A 385 - MET A 816	None	1.26A	NA	20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3jxv	70 KDA PEPTIDYL-PROLYL ISOMERASE (Triticum aestivum)	FKBP_C	5	HIS A 207 - HIS A 613 ALA A 215 - ALA A 779 ALA A 211 - ALA A 783 LEU A 255 - LEU A 804 ILE A 159 - ILE A 813	None	1.31A	NA	20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4qaw	XYN30D (Paenibacillus barcinonensis)	CBM_6	5	TYR A 54 - TYR A 612 HIS A 23 - HIS A 613 ALA A 81 - ALA A 783 ILE A 133 - ILE A 813 MET A 170 - MET A 816	None	1.32A	NA	18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ddj	CBS DOMAIN-CONTAINING PROTEIN (Sulfolobus solfataricus)	CBS	5	ALA A 196 - ALA A 779 VAL A 197 - VAL A 782 ALA A 194 - ALA A 783 PHE A 24 - PHE A 786 LEU A 51 - LEU A 804	None	1.42A	NA	24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3cwn	TRANSALDOLASE B (Escherichia coli)	TAL_FSA	5	TYR A 218 - TYR A 612 ALA A 170 - ALA A 779 ALA A 166 - ALA A 783 LEU A 158 - LEU A 804 ILE A 140 - ILE A 813	None	1.43A	NA	26.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2e1d	TRANSALDOLASE (Mus musculus)	TAL_FSA	5	TYR A 229 - TYR A 612 ALA A 181 - ALA A 779 ALA A 177 - ALA A 783 LEU A 169 - LEU A 804 ILE A 150 - ILE A 813	None	1.46A	NA	23.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1tbf	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	6	LEU A 725 - LEU A 725 LEU A 765 - LEU A 765 ALA A 767 - ALA A 767 ILE A 768 - ILE A 768 PHE A 820 - PHE A 820 ILE A 824 - ILE A 824	None VIA  A 501 ( 4.8A) VIA  A 501 ( 4.0A) None VIA  A 501 (-3.7A) None	0.00A	57.9	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5jo3	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	6	LEU B 725 - LEU A 725 LEU B 765 - LEU A 765 ALA B 767 - ALA A 767 ILE B 768 - ILE A 768 PHE B 820 - PHE A 820 ILE B 824 - ILE A 824	None 6LK  B 903 (-4.5A) 6LK  B 903 (-3.5A) 6LK  B 903 (-4.2A) 6LK  B 903 (-3.4A) None	0.56A	54.3	99.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ksm	ABC-TYPE SUGAR TRANSPORT SYSTEM, PERIPLASMIC COMPONENT (Hahella chejuensis)	Peripla_BP_4	5	LEU A 264 - LEU A 725 ALA A 243 - ALA A 767 ILE A 244 - ILE A 768 PHE A 255 - PHE A 820 ILE A 273 - ILE A 824	None	0.82A	NA	22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1bu8	PROTEIN (PANCREATIC LIPASE RELATED PROTEIN 2) (Rattus norvegicus)	Lipase PLAT	5	LEU A 131 - LEU A 765 ALA A 129 - ALA A 767 ILE A 128 - ILE A 768 PHE A 72 - PHE A 820 ILE A 102 - ILE A 824	None	0.87A	NA	21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ac8	MYCOBACTERIUM SMEGMATIS MFD (Mycobacterium smegmatis mc2 155)	CarD_CdnL_TRCF DEAD Helicase_C TRCF UvrB_inter	5	LEU A 481 - LEU A 725 LEU A 16 - LEU A 765 ALA A 14 - ALA A 767 ILE A 13 - ILE A 768 ILE A 483 - ILE A 824	None None SO4  A1306 (-4.5A) None None	0.94A	NA	14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3kv0	HET-C2 (Podospora anserina)	GLTP	5	LEU A 107 - LEU A 725 LEU A 197 - LEU A 765 ILE A 193 - ILE A 768 PHE A 41 - PHE A 820 ILE A 88 - ILE A 824	None MLY  A 198 ( 4.3A) MLY  A 192 ( 4.3A) None None	0.94A	NA	23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3sxx	PEROXISOMAL PRIMARY AMINE OXIDASE (Pichia angusta)	Cu_amine_oxid Cu_amine_oxidN2 Cu_amine_oxidN3	5	LEU A 643 - LEU A 765 ALA A 418 - ALA A 767 ILE A 419 - ILE A 768 PHE A 293 - PHE A 820 ILE A 464 - ILE A 824	None	0.94A	NA	18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4xai	MALTOSE-BINDING PERIPLASMIC PROTEIN,TAILLESS ORTHOLOG (Escherichia coli o157:h7; tribolium castaneum; synthetic construct)	SBP_bac_1	5	LEU A1292 - LEU A 725 LEU A1300 - LEU A 765 ALA A1302 - ALA A 767 ILE A1303 - ILE A 768 ILE A1358 - ILE A 824	None	0.96A	NA	22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4udq	GLUCOSE-METHANOL-CHOLINE OXIDOREDUCTASE (Methylovorus sp. mp688)	GMC_oxred_C GMC_oxred_N	5	LEU A 458 - LEU A 725 LEU A 410 - LEU A 765 ILE A 413 - ILE A 768 PHE A 368 - PHE A 820 ILE A 310 - ILE A 824	None	1.01A	NA	20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1hc7	PROLYL-TRNA SYNTHETASE (Thermus thermophilus)	HGTP_anticodon ProRS-C_1 tRNA-synt_2b	5	LEU A 285 - LEU A 725 LEU A 185 - LEU A 765 ALA A 183 - ALA A 767 PHE A 265 - PHE A 820 ILE A 50 - ILE A 824	None	1.04A	NA	21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3hjv	MALONYL COA-ACYL CARRIER PROTEIN TRANSACYLASE (Vibrio cholerae)	Acyl_transf_1	5	LEU A 118 - LEU A 725 ALA A 251 - ALA A 767 ILE A 248 - ILE A 768 PHE A 226 - PHE A 820 ILE A 110 - ILE A 824	None	1.09A	NA	20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3nrg	TETR FAMILY TRANSCRIPTIONAL REGULATOR (Chloroflexus aurantiacus)	TetR_N	5	LEU A 174 - LEU A 765 ALA A 179 - ALA A 767 ILE A 175 - ILE A 768 PHE A 102 - PHE A 820 ILE A 98 - ILE A 824	None	1.09A	NA	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2okc	TYPE I RESTRICTION ENZYME STYSJI M PROTEIN (Bacteroides thetaiotaomicron vpi-5482)	HsdM_N N6_Mtase	5	LEU A 330 - LEU A 725 LEU A 425 - LEU A 765 ILE A 427 - ILE A 768 PHE A 364 - PHE A 820 ILE A 333 - ILE A 824	None	1.11A	NA	22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4b63	L-ORNITHINE N5 MONOOXYGENASE (Aspergillus fumigatus)	K_oxygenase	5	LEU A 31 - LEU A 725 ALA A 53 - ALA A 767 ILE A 54 - ILE A 768 PHE A 81 - PHE A 820 ILE A 79 - ILE A 824	None	1.12A	NA	22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4cj0	ENDOGLUCANASE D (Clostridium thermocellum; synthetic construct)	CelD_N Dockerin_1 Glyco_hydro_9	5	LEU A 487 - LEU A 765 ALA A 489 - ALA A 767 ILE A 490 - ILE A 768 PHE A 571 - PHE A 820 ILE A 62 - ILE A 824	None	1.12A	NA	20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3si2	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE (Mus musculus)	Peptidase_M28	5	LEU A 321 - LEU A 725 LEU A 272 - LEU A 765 ALA A 274 - ALA A 767 ILE A 275 - ILE A 768 ILE A 352 - ILE A 824	None	1.22A	NA	22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3nyi	FAT ACID-BINDING PROTEIN (Eubacterium ventriosum)	DegV	5	LEU A 152 - LEU A 725 LEU A 131 - LEU A 765 ILE A 132 - ILE A 768 PHE A 87 - PHE A 820 ILE A 119 - ILE A 824	None	1.22A	NA	22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3lyk	STRINGENT STARVATION PROTEIN A HOMOLOG (Haemophilus influenzae)	GST_C	5	LEU A 165 - LEU A 725 LEU A 136 - LEU A 765 ILE A 139 - ILE A 768 PHE A 143 - PHE A 820 ILE A 183 - ILE A 824	None	1.23A	NA	20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3b8a	HEXOKINASE-1 (Saccharomyces cerevisiae)	Hexokinase_1 Hexokinase_2	5	LEU X 56 - LEU A 725 ALA X 402 - ALA A 767 ILE X 403 - ILE A 768 PHE X 240 - PHE A 820 ILE X 266 - ILE A 824	None	1.27A	NA	22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4nho	PROBABLE ATP-DEPENDENT RNA HELICASE DDX23 (Homo sapiens)	DEAD Helicase_C	5	LEU A 680 - LEU A 725 LEU A 655 - LEU A 765 ALA A 657 - ALA A 767 ILE A 658 - ILE A 768 ILE A 669 - ILE A 824	None	1.28A	NA	20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nkg	RHAMNOGALACTURONASE B (Aspergillus aculeatus)	CBM-like RhgB_N fn3_3	5	LEU A 55 - LEU A 725 LEU A 78 - LEU A 765 ALA A 99 - ALA A 767 ILE A 97 - ILE A 768 ILE A 51 - ILE A 824	None	1.29A	NA	18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3rp8	FLAVOPROTEIN MONOOXYGENASE (Klebsiella pneumoniae)	FAD_binding_3	5	LEU A 207 - LEU A 725 LEU A 252 - LEU A 765 ALA A 254 - ALA A 767 ILE A 253 - ILE A 768 PHE A 219 - PHE A 820	None	1.30A	NA	25.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3w0l	GLUCOKINASE REGULATORY PROTEIN (Xenopus laevis)	NA	5	LEU B 406 - LEU A 725 LEU B 315 - LEU A 765 ALA B 313 - ALA A 767 ILE B 312 - ILE A 768 ILE B 435 - ILE A 824	None	1.35A	NA	22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2bw3	TRANSPOSASE (Musca domestica)	DBD_Tnp_Hermes Dimer_Tnp_hAT	5	LEU A 257 - LEU A 725 LEU A 228 - LEU A 765 ALA A 230 - ALA A 767 ILE A 231 - ILE A 768 ILE A 179 - ILE A 824	None	1.37A	NA	21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2zf8	COMPONENT OF SODIUM-DRIVEN POLAR FLAGELLAR MOTOR (Vibrio alginolyticus)	MotY_N OmpA	5	LEU A 173 - LEU A 725 LEU A 181 - LEU A 765 ALA A 185 - ALA A 767 ILE A 184 - ILE A 768 ILE A 163 - ILE A 824	None	1.37A	NA	22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5i92	GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE (Pseudomonas aeruginosa)	Aminotran_3	5	LEU A 64 - LEU A 765 ALA A 406 - ALA A 767 ILE A 405 - ILE A 768 PHE A 320 - PHE A 820 ILE A 315 - ILE A 824	None	1.38A	NA	21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1fnn	CELL DIVISION CONTROL PROTEIN 6 (Pyrobaculum aerophilum)	AAA_22 Cdc6_C	5	LEU A 282 - LEU A 725 LEU A 293 - LEU A 765 ALA A 295 - ALA A 767 ILE A 296 - ILE A 768 ILE A 346 - ILE A 824	None	1.38A	NA	21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2vz8	FATTY ACID SYNTHASE (Sus scrofa)	ADH_zinc_N Acyl_transf_1 KAsynt_C_assoc KR Ketoacyl-synt_C Methyltransf_12 PP-binding PS-DH Thioesterase ketoacyl-synt	5	LEU A 404 - LEU A 725 LEU A 341 - LEU A 765 ALA A 339 - ALA A 767 ILE A 342 - ILE A 768 ILE A 6 - ILE A 824	None	1.41A	NA	8.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nu4	U1A RNA BINDING DOMAIN (Homo sapiens)	RRM_1	5	LEU A 17 - LEU A 725 LEU A 30 - LEU A 765 ALA A 32 - ALA A 767 ILE A 33 - ILE A 768 ILE A 14 - ILE A 824	None	1.41A	NA	13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4pkd	U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A,U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA (Sus scrofa; homo sapiens; synthetic construct)	RRM_1	5	LEU B 17 - LEU A 725 LEU B 30 - LEU A 765 ALA B 32 - ALA A 767 ILE B 33 - ILE A 768 ILE B 14 - ILE A 824	None	1.43A	NA	18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3w6j	SCPA (Geobacillus stearothermophilus)	NA	5	LEU A 21 - LEU A 725 LEU A 69 - LEU A 765 ALA A 71 - ALA A 767 ILE A 72 - ILE A 768 ILE A 40 - ILE A 824	None	1.44A	NA	20.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5u00	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	4	LEU A 770 - LEU A 725 LEU A 809 - LEU A 765 PHE A 862 - PHE A 820 ILE A 866 - ILE A 824	None 7OV  A1001 ( 4.6A) 7OV  A1001 (-3.9A) None	0.35A	44.3	36.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2dly	FYN-RELATED KINASE (Mus musculus)	SH2	4	LEU A 106 - LEU A 725 LEU A 56 - LEU A 765 ILE A 69 - ILE A 768 PHE A 91 - PHE A 820	None	0.44A	NA	15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3i3w	PHOSPHOGLUCOSAMINE MUTASE (Francisella tularensis subsp. tularensis)	PGM_PMM_I PGM_PMM_II PGM_PMM_III PGM_PMM_IV	4	LEU A 27 - LEU A 725 LEU A 112 - LEU A 765 PHE A 5 - PHE A 820 ILE A 10 - ILE A 824	None	0.45A	NA	20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3hc7	GENE 12 PROTEIN (Mycobacterium phage d29)	Cutinase	4	LEU A 204 - LEU A 725 ALA A 221 - ALA A 767 ILE A 222 - ILE A 768 ILE A 186 - ILE A 824	None	0.46A	NA	20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3dzd	TRANSCRIPTIONAL REGULATOR (NTRC FAMILY) (Aquifex aeolicus)	Response_reg Sigma54_activat	4	LEU A 21 - LEU A 765 ILE A 20 - ILE A 768 PHE A 109 - PHE A 820 ILE A 113 - ILE A 824	None	0.49A	NA	22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2v4u	CTP SYNTHASE 2 (Homo sapiens)	GATase	4	LEU A 382 - LEU A 765 ALA A 384 - ALA A 767 ILE A 385 - ILE A 768 ILE A 407 - ILE A 824	None	0.49A	NA	25.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1co6	PROTEIN (CYTOCHROME C2) (Blastochloris viridis)	Cytochrom_C	4	LEU A 93 - LEU A 765 ILE A 94 - ILE A 768 PHE A 63 - PHE A 820 ILE A 67 - ILE A 824	None None HEC  A 108 (-4.7A) None	0.51A	NA	14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1wqu	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES/FPS (Homo sapiens)	SH2	4	LEU A 103 - LEU A 725 LEU A 51 - LEU A 765 ILE A 64 - ILE A 768 ILE A 85 - ILE A 824	None	0.53A	NA	17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4pkd	U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A,U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA (Sus scrofa; homo sapiens; synthetic construct)	RRM_1	4	LEU B 30 - LEU A 765 ALA B 32 - ALA A 767 ILE B 33 - ILE A 768 PHE B 77 - PHE A 820	None	0.54A	NA	18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4eo9	2,3-BISPHOSPHOGLYCERATE-DEPENDENT PHOSPHOGLYCERATE MUTASE (Mycobacterium leprae)	His_Phos_1	4	LEU A 192 - LEU A 725 LEU A 9 - LEU A 765 ALA A 7 - ALA A 767 ILE A 182 - ILE A 824	None	0.56A	NA	21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5v4s	TRANSPORTER, CATION CHANNEL FAMILY / CYCLIC NUCLEOTIDE-BINDING DOMAIN MULTI-DOMAIN PROTEIN (Leptospira licerasiae serovar varillal str. var 010)	Ion_trans cNMP_binding	4	LEU A 133 - LEU A 725 LEU A 151 - LEU A 765 ALA A 153 - ALA A 767 ILE A 129 - ILE A 824	None	0.56A	NA	24.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4qhj	UNCHARACTERIZED PROTEIN MJ1213 (Methanocaldococcus jannaschii)	Peptidase_M56	4	LEU A 7 - LEU A 725 LEU A 55 - LEU A 765 ILE A 54 - ILE A 768 ILE A 63 - ILE A 824	None	0.56A	NA	16.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5cuw	SRTE1 (Streptomyces coelicolor (strain atcc baa-471 / a3(2) / m145))	Sortase	4	LEU A 317 - LEU A 725 LEU A 200 - LEU A 765 ALA A 198 - ALA A 767 ILE A 271 - ILE A 824	None	0.57A	NA	20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3qio	GAG-POL POLYPROTEIN,RIBONUCLEASE HI,GAG-POL POLYPROTEIN (Human immunodeficiency virus type 1 group m subtype b; escherichia coli (strain k12); human immunodeficiency virus type 1 group m subtype b (isolate hxb2))	RNase_H	4	LEU A 479 - LEU A 765 ALA A 481 - ALA A 767 ILE A 482 - ILE A 768 ILE A 505 - ILE A 824	None	0.57A	NA	17.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4v2x	ENDO-BETA-1,4-GLUCANASE (CELLULASE B) (Bacillus halodurans)	CBM46 CBM_X2 Cellulase	4	LEU A 425 - LEU A 765 ALA A 427 - ALA A 767 ILE A 428 - ILE A 768 ILE A 373 - ILE A 824	None	0.58A	NA	23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1sa3	TYPE II RESTRICTION ENZYME MSPI (Moraxella sp.; synthetic construct)	Endonuc-MspI	4	LEU A 48 - LEU A 725 LEU A 67 - LEU A 765 ALA A 69 - ALA A 767 ILE A 77 - ILE A 824	None	0.58A	NA	23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3igh	UNCHARACTERIZED METAL-DEPENDENT HYDROLASE (Pyrococcus horikoshii)	Amidohydro_3	4	LEU X 138 - LEU A 765 ALA X 140 - ALA A 767 ILE X 141 - ILE A 768 ILE X 147 - ILE A 824	None	0.58A	NA	22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4pv4	PROLINE AMINOPEPTIDASE P II (Yersinia pestis)	AMP_N Peptidase_M24	4	LEU A 323 - LEU A 725 LEU A 385 - LEU A 765 ILE A 402 - ILE A 768 ILE A 290 - ILE A 824	None	0.58A	NA	22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3cbl	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES/FPS (Homo sapiens; synthetic construct)	PK_Tyr_Ser-Thr SH2	4	LEU A 545 - LEU A 725 LEU A 493 - LEU A 765 ILE A 506 - ILE A 768 ILE A 527 - ILE A 824	None	0.58A	NA	20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ag9	FLAVODOXIN (Escherichia coli)	Flavodoxin_1	4	LEU A 52 - LEU A 725 LEU A 73 - LEU A 765 PHE A 78 - PHE A 820 ILE A 109 - ILE A 824	None	0.59A	NA	20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5h5x	PUTATIVE OXIDOREDUCTASE (Streptomyces coelicolor (strain atcc baa-471 / a3(2) / m145))	adh_short_C2	4	LEU A 140 - LEU A 765 ALA A 142 - ALA A 767 ILE A 143 - ILE A 768 ILE A 195 - ILE A 824	None	0.60A	NA	19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ci9	PROTEIN (CARBOXYLESTERASE) (Burkholderia gladioli)	Beta-lactamase	4	LEU A 302 - LEU A 725 LEU A 96 - LEU A 765 ALA A 98 - ALA A 767 ILE A 121 - ILE A 768	None	0.60A	NA	20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1otk	PHENYLACETIC ACID DEGRADATION PROTEIN PAAC (Escherichia coli)	NA	4	LEU A 5 - LEU A 725 LEU A 120 - LEU A 765 ALA A 122 - ALA A 767 ILE A 123 - ILE A 768	None	0.60A	NA	20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2v3z	XAA-PRO AMINOPEPTIDASE (Escherichia coli; synthetic construct)	AMP_N Peptidase_M24	4	LEU A 325 - LEU A 725 LEU A 386 - LEU A 765 ILE A 403 - ILE A 768 ILE A 292 - ILE A 824	None	0.60A	NA	21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3wqb	EXTRACELLULAR SERINE PROTEASE (Aeromonas sobria)	P_proprotein Peptidase_S8	4	LEU A 365 - LEU A 725 ALA A 136 - ALA A 767 ILE A 135 - ILE A 768 ILE A 417 - ILE A 824	None	0.60A	NA	21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3haz	PROLINE DEHYDROGENASE (Bradyrhizobium japonicum usda 110)	Aldedh Pro_dh Pro_dh-DNA_bdg	4	LEU A 904 - LEU A 765 ALA A 906 - ALA A 767 ILE A 907 - ILE A 768 ILE A 929 - ILE A 824	None	0.60A	NA	15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5kaz	SH2 DOMAIN-CONTAINING PROTEIN 1B (Homo sapiens)	SH2	4	LEU A 97 - LEU A 725 LEU A 42 - LEU A 765 ILE A 55 - ILE A 768 ILE A 83 - ILE A 824	None	0.61A	NA	15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4g1q	REVERSE TRANSCRIPTASE/RIBONUCLEASE H (Human immunodeficiency virus type 1)	RVT_1 RVT_connect RVT_thumb	4	LEU A 479 - LEU A 765 ALA A 481 - ALA A 767 ILE A 482 - ILE A 768 ILE A 505 - ILE A 824	None	0.61A	NA	20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3eo8	BLUB-LIKE FLAVOPROTEIN (Clostridium difficile 630)	Nitroreductase	4	LEU A 150 - LEU A 765 ALA A 152 - ALA A 767 ILE A 153 - ILE A 768 ILE A 7 - ILE A 824	None	0.61A	NA	19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3dds	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	Phosphorylase	4	LEU A 765 - LEU A 725 LEU A 581 - LEU A 765 ILE A 584 - ILE A 768 ILE A 742 - ILE A 824	None	0.61A	NA	17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4c91	ALPHA-GLUCURONIDASE GH115 (Bacteroides ovatus)	GH115_C Glyco_hydro_115	4	LEU A 46 - LEU A 725 LEU A 160 - LEU A 765 ILE A 157 - ILE A 768 ILE A 96 - ILE A 824	None	0.61A	NA	15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2erf	THROMBOSPONDIN-1 (Homo sapiens)	NA	4	LEU A 130 - LEU A 725 LEU A 149 - LEU A 765 ALA A 147 - ALA A 767 ILE A 138 - ILE A 824	None	0.61A	NA	19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2mca	UNCHARACTERIZED PROTEIN (Eubacterium rectale)	DUF5300	4	LEU A 13 - LEU A 765 ILE A 45 - ILE A 768 PHE A 47 - PHE A 820 ILE A 11 - ILE A 824	None	0.62A	NA	14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5nny	WIPB (Legionella pneumophila)	NA	4	LEU A 137 - LEU A 725 LEU A 44 - LEU A 765 ILE A 43 - ILE A 768 ILE A 113 - ILE A 824	None	0.62A	NA	23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3nvn	PLEXIN-C1 (Ectromelia virus; homo sapiens)	PSI	4	LEU B 429 - LEU A 725 LEU B 399 - LEU A 765 ILE B 416 - ILE A 768 ILE B 439 - ILE A 824	None	0.62A	NA	20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3m6i	L-ARABINITOL 4-DEHYDROGENASE (Neurospora crassa)	ADH_N ADH_zinc_N	4	LEU A 330 - LEU A 725 LEU A 197 - LEU A 765 ALA A 199 - ALA A 767 ILE A 223 - ILE A 824	None	0.62A	NA	20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2vif	SUPPRESSOR OF CYTOKINE SIGNALLING 6 (Homo sapiens)	SH2	4	LEU A 487 - LEU A 725 LEU A 420 - LEU A 765 ILE A 433 - ILE A 768 ILE A 458 - ILE A 824	None	0.62A	NA	17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5z2c	ALPHA-PROTEIN KINASE 1 (Homo sapiens)	NA	4	LEU A 239 - LEU A 725 LEU A 444 - LEU A 765 ILE A 445 - ILE A 768 ILE A 221 - ILE A 824	None	0.62A	NA	21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5tib	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,GASDERMIN-B (Escherichia coli; homo sapiens)	Gasdermin_C	4	LEU A1279 - LEU A 725 LEU A1399 - LEU A 765 ILE A1398 - ILE A 768 PHE A1332 - PHE A 820	None	0.62A	NA	22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3pi7	NADH OXIDOREDUCTASE (Mesorhizobium loti)	ADH_N ADH_zinc_N	4	LEU A 150 - LEU A 765 ALA A 152 - ALA A 767 ILE A 153 - ILE A 768 ILE A 304 - ILE A 824	None	0.62A	NA	21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1gnt	HYBRID CLUSTER PROTEIN (Desulfovibrio vulgaris)	Prismane	4	LEU A 183 - LEU A 725 LEU A 66 - LEU A 765 ALA A 68 - ALA A 767 ILE A 152 - ILE A 824	None	0.63A	NA	23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3sp1	CYSTEINYL-TRNA SYNTHETASE (Borrelia burgdorferi)	tRNA-synt_1e	4	LEU A 5 - LEU A 725 LEU A 49 - LEU A 765 ILE A 50 - ILE A 768 ILE A 235 - ILE A 824	None	0.63A	NA	23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2wzp	LACTOCOCCAL PHAGE P2 ORF16 (Lactococcus phage p2; lama glama)	Caudo_bapla16	4	ALA R 176 - ALA A 767 ILE R 179 - ILE A 768 PHE R 157 - PHE A 820 ILE R 156 - ILE A 824	None	0.63A	NA	22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4zcf	RESTRICTION ENDONUCLEASE ECOP15I, RESTRICTION SUBUNIT (Escherichia coli; synthetic construct)	RE_endonuc ResIII	4	LEU C 132 - LEU A 725 LEU C 144 - LEU A 765 ILE C 181 - ILE A 768 PHE C 99 - PHE A 820	None	0.64A	NA	16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3bge	PREDICTED ATPASE (Haemophilus influenzae)	MgsA_C	4	LEU A 294 - LEU A 765 ALA A 296 - ALA A 767 ILE A 297 - ILE A 768 ILE A 336 - ILE A 824	None	0.64A	NA	19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1f5n	INTERFERON-INDUCED GUANYLATE-BINDING PROTEIN 1 (Homo sapiens)	GBP GBP_C	4	LEU A 13 - LEU A 725 LEU A 31 - LEU A 765 ALA A 33 - ALA A 767 ILE A 34 - ILE A 768	None	0.64A	NA	20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nc7	HYPOTHETICAL PROTEIN TM1070 (Thermotoga maritima)	ASRT	4	LEU A 68 - LEU A 765 ILE A 73 - ILE A 768 PHE A 44 - PHE A 820 ILE A 81 - ILE A 824	None	0.64A	NA	20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3qok	PUTATIVE CHITINASE II (Klebsiella pneumoniae subsp. pneumoniae)	Glyco_hydro_18	4	LEU A 84 - LEU A 725 LEU A 109 - LEU A 765 ILE A 148 - ILE A 768 ILE A 139 - ILE A 824	None	0.64A	NA	23.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nu4	U1A RNA BINDING DOMAIN (Homo sapiens)	RRM_1	4	LEU A 30 - LEU A 765 ALA A 32 - ALA A 767 ILE A 33 - ILE A 768 PHE A 77 - PHE A 820	None	0.64A	NA	13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5kvk	PROTEIN KP700603 (Klebsiella pneumoniae 700603)	CinA	4	LEU A 162 - LEU A 725 LEU A 23 - LEU A 765 ALA A 25 - ALA A 767 ILE A 104 - ILE A 824	None	0.64A	NA	18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3dxq	CHOLINE/ETHANOLAMINE KINASE FAMILY PROTEIN (Mesorhizobium loti)	Choline_kinase	4	LEU A 23 - LEU A 725 LEU A 10 - LEU A 765 ALA A 12 - ALA A 767 ILE A 13 - ILE A 768	None	0.64A	NA	21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4hku	TETR TRANSCRIPTIONAL REGULATOR (Listeria monocytogenes)	TetR_C_27 TetR_N	4	LEU A 125 - LEU A 765 ALA A 123 - ALA A 767 PHE A 68 - PHE A 820 ILE A 67 - ILE A 824	None	0.64A	NA	20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3kts	GLYCEROL UPTAKE OPERON ANTITERMINATOR REGULATORY PROTEIN (Listeria monocytogenes str. 4b)	NA	4	LEU A 41 - LEU A 725 LEU A 57 - LEU A 765 ILE A 84 - ILE A 768 ILE A 79 - ILE A 824	None	0.64A	NA	21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ima	BACTERIOFERRITIN COMIGRATORY PROTEIN (Xanthomonas campestris pv. campestris (strain atcc 33913 / dsm 3586 / ncppb 528 / lmg 568 / p 25))	AhpC-TSA	4	LEU A 101 - LEU A 725 LEU A 27 - LEU A 765 ALA A 29 - ALA A 767 ILE A 37 - ILE A 824	None	0.65A	NA	18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2afw	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE (Homo sapiens)	Peptidase_M28	4	LEU A 318 - LEU A 725 LEU A 271 - LEU A 765 ALA A 273 - ALA A 767 ILE A 274 - ILE A 768	None	0.65A	NA	22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4g6c	BETA-HEXOSAMINIDASE 1 (Burkholderia cenocepacia)	Glyco_hydro_3	4	LEU A 197 - LEU A 765 ALA A 195 - ALA A 767 ILE A 196 - ILE A 768 ILE A 239 - ILE A 824	None	0.65A	NA	23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3pih	UVRABC SYSTEM PROTEIN A (Thermotoga maritima; synthetic construct)	ABC_tran UvrA_DNA-bind UvrA_inter	4	LEU A 635 - LEU A 725 LEU A 590 - LEU A 765 ALA A 588 - ALA A 767 ILE A 652 - ILE A 824	None	0.65A	NA	16.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ew8	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	PK_Tyr_Ser-Thr	4	LEU A 465 - LEU A 725 LEU A 525 - LEU A 765 ALA A 520 - ALA A 767 ILE A 529 - ILE A 824	None	0.65A	NA	20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2qq8	TBC1 DOMAIN FAMILY MEMBER 14 (Homo sapiens)	RabGAP-TBC	4	LEU A 504 - LEU A 765 ILE A 503 - ILE A 768 PHE A 465 - PHE A 820 ILE A 464 - ILE A 824	None	0.65A	NA	26.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1xkn	PUTATIVE PEPTIDYL-ARGININE DEIMINASE (Chlorobium tepidum)	PAD_porph	4	LEU A 155 - LEU A 725 LEU A 193 - LEU A 765 ILE A 199 - ILE A 768 ILE A 160 - ILE A 824	None	0.65A	NA	22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2d4a	MALATE DEHYDROGENASE (Aeropyrum pernix)	Ldh_1_C Ldh_1_N	4	LEU B 18 - LEU A 725 ALA B 235 - ALA A 767 ILE B 236 - ILE A 768 ILE B 2 - ILE A 824	None	0.65A	NA	22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4k5s	OXYGENASE (Streptomyces argillaceus)	FAD_binding_3	4	LEU A 309 - LEU A 725 LEU A 117 - LEU A 765 ALA A 115 - ALA A 767 PHE A 73 - PHE A 820	None	0.65A	NA	20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3mru	AMINOACYL-HISTIDINE DIPEPTIDASE (Vibrio alginolyticus)	M20_dimer Peptidase_M20	4	LEU A 77 - LEU A 725 LEU A 483 - LEU A 765 ALA A 485 - ALA A 767 ILE A 141 - ILE A 824	None	0.66A	NA	21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5e31	PENICILLIN BINDING PROTEIN 2 PRIME (Enterococcus faecium do)	MecA_N PBP_dimer Transpeptidase	4	LEU A 274 - LEU A 725 LEU A 568 - LEU A 765 ALA A 570 - ALA A 767 ILE A 569 - ILE A 768	None	0.66A	NA	20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4y4q	SORTASE, SRTB FAMILY (Streptococcus pneumoniae pcs8235)	Sortase	4	LEU A 238 - LEU A 765 ALA A 254 - ALA A 767 ILE A 236 - ILE A 768 ILE A 127 - ILE A 824	None	0.66A	NA	20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3zvk	TOXIN OF TOXIN-ANTITOXIN SYSTEM (Rickettsia felis; synthetic construct)	PIN	4	LEU A 25 - LEU A 725 LEU A 5 - LEU A 765 ILE A 36 - ILE A 768 ILE A 34 - ILE A 824	None	0.67A	NA	16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5yjd	CSM3 (Staphylococcus epidermidis rp62a)	RAMPs	4	LEU A 96 - LEU A 725 ILE A 199 - ILE A 768 PHE A 166 - PHE A 820 ILE A 169 - ILE A 824	None CA  A 301 (-4.9A) None None	0.67A	NA	19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1r7j	CONSERVED HYPOTHETICAL PROTEIN SSO10A (Sulfolobus solfataricus)	HTH_45	4	LEU A 14 - LEU A 765 ALA A 12 - ALA A 767 ILE A 13 - ILE A 768 ILE A 49 - ILE A 824	None	0.67A	NA	16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3rl5	METALLOPHOSPHOESTERASE MPPED2 (Rattus norvegicus)	Metallophos	4	LEU A 162 - LEU A 765 ALA A 177 - ALA A 767 ILE A 114 - ILE A 768 ILE A 112 - ILE A 824	None	0.67A	NA	21.95
	Hit	Macromolecule/ Organism	Pfam	Res.	Residue Matches	HETATM Residue/s	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock

[["1TBF_A_VIAA501_0","5jo3","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",10,"TYR B 612-TYR A 612;HIS B 613-HIS A 613;ALA B 779-ALA A 779;VAL B 782-VAL A 782;ALA B 783-ALA A 783;PHE B 786-PHE A 786;LEU B 804-LEU A 804;ILE B 813-ILE A 813;MET B 816-MET A 816;GLN B 817-GLN A 817","None; ZN B 901 ( 4.9A);6LK B 903 (-3.7A);6LK B 903 ( 4.9A);None;None;6LK B 903 (-4.0A);None;6LK B 903 (-4.0A);6LK B 903 (-3.3A)","0.51A","54.3","99.69"],["1TBF_A_VIAA501_0","1tbf","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",9,"TYR A 612-TYR A 612;HIS A 613-HIS A 613;ALA A 779-ALA A 779;VAL A 782-VAL A 782;ALA A 783-ALA A 783;PHE A 786-PHE A 786;LEU A 804-LEU A 804;ILE A 813-ILE A 813;GLN A 817-GLN A 817","None;None;VIA A 501 (-4.6A);VIA A 501 ( 4.6A);VIA A 501 ( 3.9A);VIA A 501 (-4.9A);VIA A 501 (-4.4A);VIA A 501 ( 4.6A);VIA A 501 (-3.0A)","0.04A","57.9","100.00"],["1TBF_A_VIAA501_0","7jsn","Bos taurus","ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT BETA","GAF;PDEase_I",7,"TYR B 556-TYR A 612;HIS B 557-HIS A 613;ALA B 733-ALA A 779;VAL B 736-VAL A 782;ALA B 737-ALA A 783;PHE B 740-PHE A 786;GLN B 771-GLN A 817","None;None;None;VDN B 904 ( 4.8A);VDN B 904 ( 4.1A);None;VDN B 904 ( 3.0A)","0.50A","38.4","20.05"],["1TBF_A_VIAA501_0","1tbf","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",7,"TYR A 612-TYR A 612;HIS A 613-HIS A 613;VAL A 782-VAL A 782;PHE A 786-PHE A 786;LEU A 804-LEU A 804;MET A 816-MET A 816;GLN A 817-GLN A 817","None;None;VIA A 501 ( 4.6A);VIA A 501 (-4.9A);VIA A 501 (-4.4A);VIA A 501 ( 4.3A);VIA A 501 (-3.0A)","0.61A","57.9","100.00"],["1TBF_A_VIAA501_0","5u00","Homo sapiens","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",6,"TYR A 655-TYR A 612;HIS A 656-HIS A 613;ALA A 823-ALA A 779;PHE A 830-PHE A 786;ILE A 855-ILE A 813;GLN A 859-GLN A 817","None;7OV A1001 (-4.0A);None;7OV A1001 (-4.3A);None;7OV A1001 (-3.1A)","0.40A","44.3","36.09"],["1TBF_A_VIAA501_0","6cyc","Homo sapiens","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",6,"TYR A 655-TYR A 612;HIS A 656-HIS A 613;ALA A 823-ALA A 779;PHE A 830-PHE A 786;ILE A 855-ILE A 813;GLN A 859-GLN A 817","FKJ A1003 (-4.7A);FKJ A1003 (-4.6A);None;EDO A1005 ( 3.8A);None;FKJ A1003 (-3.0A)","0.47A","43.4","35.19"],["1TBF_A_VIAA501_0","7jsn","Bos taurus","ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA","GAF;PDEase_I",6,"TYR A 558-TYR A 612;HIS A 559-HIS A 613;ALA A 735-ALA A 779;VAL A 738-VAL A 782;ALA A 739-ALA A 783;PHE A 742-PHE A 786","None;None;None;None;VDN A 904 ( 3.9A);None","0.51A","23.1","20.00"],["1TBF_A_VIAA501_0","1zkl","Homo sapiens","HIGH-AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A","PDEase_I",6,"TYR A 211-TYR A 612;HIS A 212-HIS A 613;VAL A 380-VAL A 782;PHE A 384-PHE A 786;ILE A 409-ILE A 813;GLN A 413-GLN A 817","IBM A 503 (-4.6A);None;IBM A 503 (-4.7A);IBM A 503 (-4.5A);None;IBM A 503 (-3.0A)","0.51A","38.5","29.52"],["1TBF_A_VIAA501_0","2r8q","Leishmania major","CLASS I PHOSPHODIESTERASE PDEB1","PDEase_I",6,"TYR A 680-TYR A 612;HIS A 681-HIS A 613;ALA A 850-ALA A 779;VAL A 853-VAL A 782;PHE A 857-PHE A 786;GLN A 887-GLN A 817","IBM A 3 ( 4.7A);IBM A 3 ( 4.8A);None;IBM A 3 ( 4.8A);IBM A 3 (-4.9A);IBM A 3 (-3.3A)","0.51A","40.8","31.69"],["1TBF_A_VIAA501_0","6fe3","Trypanosoma brucei","PHOSPHODIESTERASE","PDEase_I",6,"TYR A 668-TYR A 612;HIS A 669-HIS A 613;ALA A 837-ALA A 779;VAL A 840-VAL A 782;PHE A 844-PHE A 786;GLN A 874-GLN A 817","None;None;D68 A1003 (-4.0A);D68 A1003 (-4.9A);D68 A1003 (-4.9A);D68 A1003 (-3.2A)","0.63A","39.9","31.65"],["1TBF_A_VIAA501_0","5h2q","Trypanosoma brucei brucei","PHOSPHODIESTERASE","PDEase_I",5,"TYR A 668-TYR A 612;HIS A 669-HIS A 613;ALA A 838-ALA A 779;VAL A 841-VAL A 782;PHE A 845-PHE A 786","LLI A1003 ( 4.9A);None;LLI A1003 ( 4.3A);LLI A1003 (-4.6A);LLI A1003 (-4.6A)","0.36A","40.9","33.71"],["1TBF_A_VIAA501_0","3ecm","Homo sapiens","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","PDEase_I",5,"TYR A 555-TYR A 612;HIS A 556-HIS A 613;ALA A 741-ALA A 779;ILE A 774-ILE A 813;GLN A 778-GLN A 817","None","0.43A","38.4","27.30"],["1TBF_A_VIAA501_0","5h2q","Trypanosoma brucei brucei","PHOSPHODIESTERASE","PDEase_I",5,"TYR A 668-TYR A 612;HIS A 669-HIS A 613;ALA A 838-ALA A 779;VAL A 841-VAL A 782;GLN A 875-GLN A 817","LLI A1003 ( 4.9A);None;LLI A1003 ( 4.3A);LLI A1003 (-4.6A);LLI A1003 (-3.1A)","0.54A","40.9","33.71"],["1TBF_A_VIAA501_0","7jsn","Bos taurus","ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA","GAF;PDEase_I",5,"HIS A 559-HIS A 613;ALA A 735-ALA A 779;VAL A 738-VAL A 782;ALA A 739-ALA A 783;GLN A 773-GLN A 817","None;None;None;VDN A 904 ( 3.9A);VDN A 904 ( 3.3A)","0.59A","23.1","20.00"],["1TBF_A_VIAA501_0","3so6","Rattus norvegicus;synthetic construct","LDL RECEPTOR ADAPTOR PROTEIN","PID",5,"ALA A 163-ALA A 779;VAL A 166-VAL A 782;ALA A 167-ALA A 783;PHE A 170-PHE A 786;ILE A 112-ILE A 813","None","0.62A","NA","20.06"],["1TBF_A_VIAA501_0","1zkl","Homo sapiens","HIGH-AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A","PDEase_I",5,"HIS A 212-HIS A 613;VAL A 380-VAL A 782;PHE A 384-PHE A 786;LEU A 401-LEU A 804;GLN A 413-GLN A 817","None;IBM A 503 (-4.7A);IBM A 503 (-4.5A);None;IBM A 503 (-3.0A)","0.73A","38.5","29.52"],["1TBF_A_VIAA501_0","2dfa","Thermus thermophilus","HYPOTHETICAL UPF0271 PROTEIN TTHB195","LamB_YcsF",5,"ALA A 229-ALA A 779;VAL A 232-VAL A 782;ALA A 233-ALA A 783;LEU A 5-LEU A 804;ILE A 24-ILE A 813","None","0.94A","NA","20.22"],["1TBF_A_VIAA501_0","4uej","Escherichia coli","GALACTITOL-1-PHOSPHATE 5-DEHYDROGENASE","ADH_N;ADH_zinc_N",5,"ALA A 250-ALA A 779;VAL A 247-VAL A 782;ALA A 246-ALA A 783;LEU A 258-LEU A 804;ILE A 233-ILE A 813","None","0.95A","NA","22.04"],["1TBF_A_VIAA501_0","5oes","Solanum tuberosum","GLUTATHIONE SYNTHETASE","GSH_synth_ATP;GSH_synthase",5,"ALA A 77-ALA A 779;VAL A 80-VAL A 782;ALA A 81-ALA A 783;PHE A 84-PHE A 786;LEU A 154-LEU A 804","None","1.01A","NA","21.50"],["1TBF_A_VIAA501_0","5oes","Solanum tuberosum","GLUTATHIONE SYNTHETASE","GSH_synth_ATP;GSH_synthase",5,"VAL A 80-VAL A 782;ALA A 81-ALA A 783;PHE A 84-PHE A 786;LEU A 154-LEU A 804;ILE A 437-ILE A 813","None","1.05A","NA","21.50"],["1TBF_A_VIAA501_0","4ft4","Zea mays;synthetic construct","DNA (CYTOSINE-5)-METHYLTRANSFERASE 1","BAH;Chromo;DNA_methylase",5,"TYR B 597-TYR A 612;ALA B 854-ALA A 779;VAL B 857-VAL A 782;ALA B 858-ALA A 783;LEU B 557-LEU A 804","None","1.18A","NA","18.17"],["1TBF_A_VIAA501_0","3k11","Bacteroides thetaiotaomicron vpi-5482","PUTATIVE GLYCOSYL HYDROLASE","Glyco_hydro_88",5,"TYR A 83-TYR A 612;VAL A 137-VAL A 782;ALA A 138-ALA A 783;PHE A 141-PHE A 786;ILE A 158-ILE A 813","None","1.20A","NA","20.95"],["1TBF_A_VIAA501_0","2ocd","Vibrio cholerae","L-ASPARAGINASE I","Asparaginase;Asparaginase_C",5,"VAL A 205-VAL A 782;PHE A 105-PHE A 786;LEU A 101-LEU A 804;ILE A 208-ILE A 813;GLN A 69-GLN A 817","None","1.22A","NA","21.28"],["1TBF_A_VIAA501_0","4i9f","Mycobacterium tuberculosis","GLYCEROL 3-PHOSPHATE PHOSPHATASE","GNAT_like;Hydrolase_6;Hydrolase_like",5,"TYR A 240-TYR A 612;ALA A 306-ALA A 779;VAL A 239-VAL A 782;ALA A 238-ALA A 783;ILE A 250-ILE A 813","None","1.23A","NA","20.37"],["1TBF_A_VIAA501_0","6sfw","Listeria monocytogenes","ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUBUNIT CLPX","AAA_2;ClpB_D2-small;zf-C4_ClpX",5,"TYR O 93-TYR A 612;ALA O 88-ALA A 779;VAL O 89-VAL A 782;ALA O 86-ALA A 783;LEU O 71-LEU A 804","None","1.25A","NA","23.52"],["1TBF_A_VIAA501_0","6pux","Mycobacterium tuberculosis (strain atcc 25618 \/ h37rv)","HOMOSERINE O-ACETYLTRANSFERASE","Abhydrolase_1",5,"ALA A 97-ALA A 779;VAL A 98-VAL A 782;ALA A 99-ALA A 783;LEU A 57-LEU A 804;ILE A 66-ILE A 813","None","1.25A","NA","22.03"],["1TBF_A_VIAA501_0","3qan","Bacillus halodurans","1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE 1","Aldedh",5,"VAL A 422-VAL A 782;ALA A 423-ALA A 783;PHE A 424-PHE A 786;LEU A 337-LEU A 804;MET A 385-MET A 816","None","1.26A","NA","20.30"],["1TBF_A_VIAA501_0","3jxv","Triticum aestivum","70 KDA PEPTIDYL-PROLYL ISOMERASE","FKBP_C",5,"HIS A 207-HIS A 613;ALA A 215-ALA A 779;ALA A 211-ALA A 783;LEU A 255-LEU A 804;ILE A 159-ILE A 813","None","1.31A","NA","20.32"],["1TBF_A_VIAA501_0","4qaw","Paenibacillus barcinonensis","XYN30D","CBM_6",5,"TYR A 54-TYR A 612;HIS A 23-HIS A 613;ALA A 81-ALA A 783;ILE A 133-ILE A 813;MET A 170-MET A 816","None","1.32A","NA","18.52"],["1TBF_A_VIAA501_0","3ddj","Sulfolobus solfataricus","CBS DOMAIN-CONTAINING PROTEIN","CBS",5,"ALA A 196-ALA A 779;VAL A 197-VAL A 782;ALA A 194-ALA A 783;PHE A 24-PHE A 786;LEU A 51-LEU A 804","None","1.42A","NA","24.10"],["1TBF_A_VIAA501_0","3cwn","Escherichia coli","TRANSALDOLASE B","TAL_FSA",5,"TYR A 218-TYR A 612;ALA A 170-ALA A 779;ALA A 166-ALA A 783;LEU A 158-LEU A 804;ILE A 140-ILE A 813","None","1.43A","NA","26.39"],["1TBF_A_VIAA501_0","2e1d","Mus musculus","TRANSALDOLASE","TAL_FSA",5,"TYR A 229-TYR A 612;ALA A 181-ALA A 779;ALA A 177-ALA A 783;LEU A 169-LEU A 804;ILE A 150-ILE A 813","None","1.46A","NA","23.12"],["1TBF_A_VIAA501_1","1tbf","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",6,"LEU A 725-LEU A 725;LEU A 765-LEU A 765;ALA A 767-ALA A 767;ILE A 768-ILE A 768;PHE A 820-PHE A 820;ILE A 824-ILE A 824","None;VIA A 501 ( 4.8A);VIA A 501 ( 4.0A);None;VIA A 501 (-3.7A);None","0.00A","57.9","100.00"],["1TBF_A_VIAA501_1","5jo3","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",6,"LEU B 725-LEU A 725;LEU B 765-LEU A 765;ALA B 767-ALA A 767;ILE B 768-ILE A 768;PHE B 820-PHE A 820;ILE B 824-ILE A 824","None;6LK B 903 (-4.5A);6LK B 903 (-3.5A);6LK B 903 (-4.2A);6LK B 903 (-3.4A);None","0.56A","54.3","99.69"],["1TBF_A_VIAA501_1","3ksm","Hahella chejuensis","ABC-TYPE SUGAR TRANSPORT SYSTEM, PERIPLASMIC COMPONENT","Peripla_BP_4",5,"LEU A 264-LEU A 725;ALA A 243-ALA A 767;ILE A 244-ILE A 768;PHE A 255-PHE A 820;ILE A 273-ILE A 824","None","0.82A","NA","22.93"],["1TBF_A_VIAA501_1","1bu8","Rattus norvegicus","PROTEIN (PANCREATIC LIPASE RELATED PROTEIN 2)","Lipase;PLAT",5,"LEU A 131-LEU A 765;ALA A 129-ALA A 767;ILE A 128-ILE A 768;PHE A 72-PHE A 820;ILE A 102-ILE A 824","None","0.87A","NA","21.70"],["1TBF_A_VIAA501_1","6ac8","Mycobacterium smegmatis mc2 155","MYCOBACTERIUM SMEGMATIS MFD","CarD_CdnL_TRCF;DEAD;Helicase_C;TRCF;UvrB_inter",5,"LEU A 481-LEU A 725;LEU A 16-LEU A 765;ALA A 14-ALA A 767;ILE A 13-ILE A 768;ILE A 483-ILE A 824","None;None;SO4 A1306 (-4.5A);None;None","0.94A","NA","14.85"],["1TBF_A_VIAA501_1","3kv0","Podospora anserina","HET-C2","GLTP",5,"LEU A 107-LEU A 725;LEU A 197-LEU A 765;ILE A 193-ILE A 768;PHE A 41-PHE A 820;ILE A 88-ILE A 824","None;MLY A 198 ( 4.3A);MLY A 192 ( 4.3A);None;None","0.94A","NA","23.85"],["1TBF_A_VIAA501_1","3sxx","Pichia angusta","PEROXISOMAL PRIMARY AMINE OXIDASE","Cu_amine_oxid;Cu_amine_oxidN2;Cu_amine_oxidN3",5,"LEU A 643-LEU A 765;ALA A 418-ALA A 767;ILE A 419-ILE A 768;PHE A 293-PHE A 820;ILE A 464-ILE A 824","None","0.94A","NA","18.30"],["1TBF_A_VIAA501_1","4xai","Escherichia coli o157:h7;tribolium castaneum;synthetic construct","MALTOSE-BINDING PERIPLASMIC PROTEIN,TAILLESS ORTHOLOG","SBP_bac_1",5,"LEU A1292-LEU A 725;LEU A1300-LEU A 765;ALA A1302-ALA A 767;ILE A1303-ILE A 768;ILE A1358-ILE A 824","None","0.96A","NA","22.98"],["1TBF_A_VIAA501_1","4udq","Methylovorus sp. mp688","GLUCOSE-METHANOL-CHOLINE OXIDOREDUCTASE","GMC_oxred_C;GMC_oxred_N",5,"LEU A 458-LEU A 725;LEU A 410-LEU A 765;ILE A 413-ILE A 768;PHE A 368-PHE A 820;ILE A 310-ILE A 824","None","1.01A","NA","20.59"],["1TBF_A_VIAA501_1","1hc7","Thermus thermophilus","PROLYL-TRNA SYNTHETASE","HGTP_anticodon;ProRS-C_1;tRNA-synt_2b",5,"LEU A 285-LEU A 725;LEU A 185-LEU A 765;ALA A 183-ALA A 767;PHE A 265-PHE A 820;ILE A 50-ILE A 824","None","1.04A","NA","21.15"],["1TBF_A_VIAA501_1","3hjv","Vibrio cholerae","MALONYL COA-ACYL CARRIER PROTEIN TRANSACYLASE","Acyl_transf_1",5,"LEU A 118-LEU A 725;ALA A 251-ALA A 767;ILE A 248-ILE A 768;PHE A 226-PHE A 820;ILE A 110-ILE A 824","None","1.09A","NA","20.33"],["1TBF_A_VIAA501_1","3nrg","Chloroflexus aurantiacus","TETR FAMILY TRANSCRIPTIONAL REGULATOR","TetR_N",5,"LEU A 174-LEU A 765;ALA A 179-ALA A 767;ILE A 175-ILE A 768;PHE A 102-PHE A 820;ILE A 98-ILE A 824","None","1.09A","NA","20.00"],["1TBF_A_VIAA501_1","2okc","Bacteroides thetaiotaomicron vpi-5482","TYPE I RESTRICTION ENZYME STYSJI M PROTEIN","HsdM_N;N6_Mtase",5,"LEU A 330-LEU A 725;LEU A 425-LEU A 765;ILE A 427-ILE A 768;PHE A 364-PHE A 820;ILE A 333-ILE A 824","None","1.11A","NA","22.15"],["1TBF_A_VIAA501_1","4b63","Aspergillus fumigatus","L-ORNITHINE N5 MONOOXYGENASE","K_oxygenase",5,"LEU A 31-LEU A 725;ALA A 53-ALA A 767;ILE A 54-ILE A 768;PHE A 81-PHE A 820;ILE A 79-ILE A 824","None","1.12A","NA","22.71"],["1TBF_A_VIAA501_1","4cj0","Clostridium thermocellum;synthetic construct","ENDOGLUCANASE D","CelD_N;Dockerin_1;Glyco_hydro_9",5,"LEU A 487-LEU A 765;ALA A 489-ALA A 767;ILE A 490-ILE A 768;PHE A 571-PHE A 820;ILE A 62-ILE A 824","None","1.12A","NA","20.09"],["1TBF_A_VIAA501_1","3si2","Mus musculus","GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE","Peptidase_M28",5,"LEU A 321-LEU A 725;LEU A 272-LEU A 765;ALA A 274-ALA A 767;ILE A 275-ILE A 768;ILE A 352-ILE A 824","None","1.22A","NA","22.16"],["1TBF_A_VIAA501_1","3nyi","Eubacterium ventriosum","FAT ACID-BINDING PROTEIN","DegV",5,"LEU A 152-LEU A 725;LEU A 131-LEU A 765;ILE A 132-ILE A 768;PHE A 87-PHE A 820;ILE A 119-ILE A 824","None","1.22A","NA","22.47"],["1TBF_A_VIAA501_1","3lyk","Haemophilus influenzae","STRINGENT STARVATION PROTEIN A HOMOLOG","GST_C",5,"LEU A 165-LEU A 725;LEU A 136-LEU A 765;ILE A 139-ILE A 768;PHE A 143-PHE A 820;ILE A 183-ILE A 824","None","1.23A","NA","20.23"],["1TBF_A_VIAA501_1","3b8a","Saccharomyces cerevisiae","HEXOKINASE-1","Hexokinase_1;Hexokinase_2",5,"LEU X 56-LEU A 725;ALA X 402-ALA A 767;ILE X 403-ILE A 768;PHE X 240-PHE A 820;ILE X 266-ILE A 824","None","1.27A","NA","22.13"],["1TBF_A_VIAA501_1","4nho","Homo sapiens","PROBABLE ATP-DEPENDENT RNA HELICASE DDX23","DEAD;Helicase_C",5,"LEU A 680-LEU A 725;LEU A 655-LEU A 765;ALA A 657-ALA A 767;ILE A 658-ILE A 768;ILE A 669-ILE A 824","None","1.28A","NA","20.83"],["1TBF_A_VIAA501_1","1nkg","Aspergillus aculeatus","RHAMNOGALACTURONASE B","CBM-like;RhgB_N;fn3_3",5,"LEU A 55-LEU A 725;LEU A 78-LEU A 765;ALA A 99-ALA A 767;ILE A 97-ILE A 768;ILE A 51-ILE A 824","None","1.29A","NA","18.81"],["1TBF_A_VIAA501_1","3rp8","Klebsiella pneumoniae","FLAVOPROTEIN MONOOXYGENASE","FAD_binding_3",5,"LEU A 207-LEU A 725;LEU A 252-LEU A 765;ALA A 254-ALA A 767;ILE A 253-ILE A 768;PHE A 219-PHE A 820","None","1.30A","NA","25.12"],["1TBF_A_VIAA501_1","3w0l","Xenopus laevis","GLUCOKINASE REGULATORY PROTEIN","NA",5,"LEU B 406-LEU A 725;LEU B 315-LEU A 765;ALA B 313-ALA A 767;ILE B 312-ILE A 768;ILE B 435-ILE A 824","None","1.35A","NA","22.12"],["1TBF_A_VIAA501_1","2bw3","Musca domestica","TRANSPOSASE","DBD_Tnp_Hermes;Dimer_Tnp_hAT",5,"LEU A 257-LEU A 725;LEU A 228-LEU A 765;ALA A 230-ALA A 767;ILE A 231-ILE A 768;ILE A 179-ILE A 824","None","1.37A","NA","21.64"],["1TBF_A_VIAA501_1","2zf8","Vibrio alginolyticus","COMPONENT OF SODIUM-DRIVEN POLAR FLAGELLAR MOTOR","MotY_N;OmpA",5,"LEU A 173-LEU A 725;LEU A 181-LEU A 765;ALA A 185-ALA A 767;ILE A 184-ILE A 768;ILE A 163-ILE A 824","None","1.37A","NA","22.13"],["1TBF_A_VIAA501_1","5i92","Pseudomonas aeruginosa","GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE","Aminotran_3",5,"LEU A 64-LEU A 765;ALA A 406-ALA A 767;ILE A 405-ILE A 768;PHE A 320-PHE A 820;ILE A 315-ILE A 824","None","1.38A","NA","21.65"],["1TBF_A_VIAA501_1","1fnn","Pyrobaculum aerophilum","CELL DIVISION CONTROL PROTEIN 6","AAA_22;Cdc6_C",5,"LEU A 282-LEU A 725;LEU A 293-LEU A 765;ALA A 295-ALA A 767;ILE A 296-ILE A 768;ILE A 346-ILE A 824","None","1.38A","NA","21.14"],["1TBF_A_VIAA501_1","2vz8","Sus scrofa","FATTY ACID SYNTHASE","ADH_zinc_N;Acyl_transf_1;KAsynt_C_assoc;KR;Ketoacyl-synt_C;Methyltransf_12;PP-binding;PS-DH;Thioesterase;ketoacyl-synt",5,"LEU A 404-LEU A 725;LEU A 341-LEU A 765;ALA A 339-ALA A 767;ILE A 342-ILE A 768;ILE A 6-ILE A 824","None","1.41A","NA","8.50"],["1TBF_A_VIAA501_1","1nu4","Homo sapiens","U1A RNA BINDING DOMAIN","RRM_1",5,"LEU A 17-LEU A 725;LEU A 30-LEU A 765;ALA A 32-ALA A 767;ILE A 33-ILE A 768;ILE A 14-ILE A 824","None","1.41A","NA","13.51"],["1TBF_A_VIAA501_1","4pkd","Sus scrofa;homo sapiens;synthetic construct","U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A,U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA","RRM_1",5,"LEU B 17-LEU A 725;LEU B 30-LEU A 765;ALA B 32-ALA A 767;ILE B 33-ILE A 768;ILE B 14-ILE A 824","None","1.43A","NA","18.72"],["1TBF_A_VIAA501_1","3w6j","Geobacillus stearothermophilus","SCPA","NA",5,"LEU A 21-LEU A 725;LEU A 69-LEU A 765;ALA A 71-ALA A 767;ILE A 72-ILE A 768;ILE A 40-ILE A 824","None","1.44A","NA","20.06"],["1TBF_A_VIAA501_1","5u00","Homo sapiens","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",4,"LEU A 770-LEU A 725;LEU A 809-LEU A 765;PHE A 862-PHE A 820;ILE A 866-ILE A 824","None;7OV A1001 ( 4.6A);7OV A1001 (-3.9A);None","0.35A","44.3","36.09"],["1TBF_A_VIAA501_1","2dly","Mus musculus","FYN-RELATED KINASE","SH2",4,"LEU A 106-LEU A 725;LEU A 56-LEU A 765;ILE A 69-ILE A 768;PHE A 91-PHE A 820","None","0.44A","NA","15.03"],["1TBF_A_VIAA501_1","3i3w","Francisella tularensis subsp. tularensis","PHOSPHOGLUCOSAMINE MUTASE","PGM_PMM_I;PGM_PMM_II;PGM_PMM_III;PGM_PMM_IV",4,"LEU A 27-LEU A 725;LEU A 112-LEU A 765;PHE A 5-PHE A 820;ILE A 10-ILE A 824","None","0.45A","NA","20.40"],["1TBF_A_VIAA501_1","3hc7","Mycobacterium phage d29","GENE 12 PROTEIN","Cutinase",4,"LEU A 204-LEU A 725;ALA A 221-ALA A 767;ILE A 222-ILE A 768;ILE A 186-ILE A 824","None","0.46A","NA","20.72"],["1TBF_A_VIAA501_1","3dzd","Aquifex aeolicus","TRANSCRIPTIONAL REGULATOR (NTRC FAMILY)","Response_reg;Sigma54_activat",4,"LEU A 21-LEU A 765;ILE A 20-ILE A 768;PHE A 109-PHE A 820;ILE A 113-ILE A 824","None","0.49A","NA","22.83"],["1TBF_A_VIAA501_1","2v4u","Homo sapiens","CTP SYNTHASE 2","GATase",4,"LEU A 382-LEU A 765;ALA A 384-ALA A 767;ILE A 385-ILE A 768;ILE A 407-ILE A 824","None","0.49A","NA","25.41"],["1TBF_A_VIAA501_1","1co6","Blastochloris viridis","PROTEIN (CYTOCHROME C2)","Cytochrom_C",4,"LEU A 93-LEU A 765;ILE A 94-ILE A 768;PHE A 63-PHE A 820;ILE A 67-ILE A 824","None;None;HEC A 108 (-4.7A);None","0.51A","NA","14.38"],["1TBF_A_VIAA501_1","1wqu","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES\/FPS","SH2",4,"LEU A 103-LEU A 725;LEU A 51-LEU A 765;ILE A 64-ILE A 768;ILE A 85-ILE A 824","None","0.53A","NA","17.42"],["1TBF_A_VIAA501_1","4pkd","Sus scrofa;homo sapiens;synthetic construct","U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A,U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA","RRM_1",4,"LEU B 30-LEU A 765;ALA B 32-ALA A 767;ILE B 33-ILE A 768;PHE B 77-PHE A 820","None","0.54A","NA","18.72"],["1TBF_A_VIAA501_1","4eo9","Mycobacterium leprae","2,3-BISPHOSPHOGLYCERATE-DEPENDENT PHOSPHOGLYCERATE MUTASE","His_Phos_1",4,"LEU A 192-LEU A 725;LEU A 9-LEU A 765;ALA A 7-ALA A 767;ILE A 182-ILE A 824","None","0.56A","NA","21.75"],["1TBF_A_VIAA501_1","5v4s","Leptospira licerasiae serovar varillal str. var 010","TRANSPORTER, CATION CHANNEL FAMILY \/ CYCLIC NUCLEOTIDE-BINDING DOMAIN MULTI-DOMAIN PROTEIN","Ion_trans;cNMP_binding",4,"LEU A 133-LEU A 725;LEU A 151-LEU A 765;ALA A 153-ALA A 767;ILE A 129-ILE A 824","None","0.56A","NA","24.95"],["1TBF_A_VIAA501_1","4qhj","Methanocaldococcus jannaschii","UNCHARACTERIZED PROTEIN MJ1213","Peptidase_M56",4,"LEU A 7-LEU A 725;LEU A 55-LEU A 765;ILE A 54-ILE A 768;ILE A 63-ILE A 824","None","0.56A","NA","16.52"],["1TBF_A_VIAA501_1","5cuw","Streptomyces coelicolor (strain atcc baa-471 \/ a3(2) \/ m145)","SRTE1","Sortase",4,"LEU A 317-LEU A 725;LEU A 200-LEU A 765;ALA A 198-ALA A 767;ILE A 271-ILE A 824","None","0.57A","NA","20.54"],["1TBF_A_VIAA501_1","3qio","Human immunodeficiency virus type 1 group m subtype b;escherichia coli (strain k12);human immunodeficiency virus type 1 group m subtype b (isolate hxb2)","GAG-POL POLYPROTEIN,RIBONUCLEASE HI,GAG-POL POLYPROTEIN","RNase_H",4,"LEU A 479-LEU A 765;ALA A 481-ALA A 767;ILE A 482-ILE A 768;ILE A 505-ILE A 824","None","0.57A","NA","17.38"],["1TBF_A_VIAA501_1","4v2x","Bacillus halodurans","ENDO-BETA-1,4-GLUCANASE (CELLULASE B)","CBM46;CBM_X2;Cellulase",4,"LEU A 425-LEU A 765;ALA A 427-ALA A 767;ILE A 428-ILE A 768;ILE A 373-ILE A 824","None","0.58A","NA","23.57"],["1TBF_A_VIAA501_1","1sa3","Moraxella sp.;synthetic construct","TYPE II RESTRICTION ENZYME MSPI","Endonuc-MspI",4,"LEU A 48-LEU A 725;LEU A 67-LEU A 765;ALA A 69-ALA A 767;ILE A 77-ILE A 824","None","0.58A","NA","23.08"],["1TBF_A_VIAA501_1","3igh","Pyrococcus horikoshii","UNCHARACTERIZED METAL-DEPENDENT HYDROLASE","Amidohydro_3",4,"LEU X 138-LEU A 765;ALA X 140-ALA A 767;ILE X 141-ILE A 768;ILE X 147-ILE A 824","None","0.58A","NA","22.04"],["1TBF_A_VIAA501_1","4pv4","Yersinia pestis","PROLINE AMINOPEPTIDASE P II","AMP_N;Peptidase_M24",4,"LEU A 323-LEU A 725;LEU A 385-LEU A 765;ILE A 402-ILE A 768;ILE A 290-ILE A 824","None","0.58A","NA","22.66"],["1TBF_A_VIAA501_1","3cbl","Homo sapiens;synthetic construct","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES\/FPS","PK_Tyr_Ser-Thr;SH2",4,"LEU A 545-LEU A 725;LEU A 493-LEU A 765;ILE A 506-ILE A 768;ILE A 527-ILE A 824","None","0.58A","NA","20.81"],["1TBF_A_VIAA501_1","1ag9","Escherichia coli","FLAVODOXIN","Flavodoxin_1",4,"LEU A 52-LEU A 725;LEU A 73-LEU A 765;PHE A 78-PHE A 820;ILE A 109-ILE A 824","None","0.59A","NA","20.56"],["1TBF_A_VIAA501_1","5h5x","Streptomyces coelicolor (strain atcc baa-471 \/ a3(2) \/ m145)","PUTATIVE OXIDOREDUCTASE","adh_short_C2",4,"LEU A 140-LEU A 765;ALA A 142-ALA A 767;ILE A 143-ILE A 768;ILE A 195-ILE A 824","None","0.60A","NA","19.06"],["1TBF_A_VIAA501_1","1ci9","Burkholderia gladioli","PROTEIN (CARBOXYLESTERASE)","Beta-lactamase",4,"LEU A 302-LEU A 725;LEU A 96-LEU A 765;ALA A 98-ALA A 767;ILE A 121-ILE A 768","None","0.60A","NA","20.09"],["1TBF_A_VIAA501_1","1otk","Escherichia coli","PHENYLACETIC ACID DEGRADATION PROTEIN PAAC","NA",4,"LEU A 5-LEU A 725;LEU A 120-LEU A 765;ALA A 122-ALA A 767;ILE A 123-ILE A 768","None","0.60A","NA","20.79"],["1TBF_A_VIAA501_1","2v3z","Escherichia coli;synthetic construct","XAA-PRO AMINOPEPTIDASE","AMP_N;Peptidase_M24",4,"LEU A 325-LEU A 725;LEU A 386-LEU A 765;ILE A 403-ILE A 768;ILE A 292-ILE A 824","None","0.60A","NA","21.51"],["1TBF_A_VIAA501_1","3wqb","Aeromonas sobria","EXTRACELLULAR SERINE PROTEASE","P_proprotein;Peptidase_S8",4,"LEU A 365-LEU A 725;ALA A 136-ALA A 767;ILE A 135-ILE A 768;ILE A 417-ILE A 824","None","0.60A","NA","21.49"],["1TBF_A_VIAA501_1","3haz","Bradyrhizobium japonicum usda 110","PROLINE DEHYDROGENASE","Aldedh;Pro_dh;Pro_dh-DNA_bdg",4,"LEU A 904-LEU A 765;ALA A 906-ALA A 767;ILE A 907-ILE A 768;ILE A 929-ILE A 824","None","0.60A","NA","15.77"],["1TBF_A_VIAA501_1","5kaz","Homo sapiens","SH2 DOMAIN-CONTAINING PROTEIN 1B","SH2",4,"LEU A 97-LEU A 725;LEU A 42-LEU A 765;ILE A 55-ILE A 768;ILE A 83-ILE A 824","None","0.61A","NA","15.00"],["1TBF_A_VIAA501_1","4g1q","Human immunodeficiency virus type 1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","RVT_1;RVT_connect;RVT_thumb",4,"LEU A 479-LEU A 765;ALA A 481-ALA A 767;ILE A 482-ILE A 768;ILE A 505-ILE A 824","None","0.61A","NA","20.64"],["1TBF_A_VIAA501_1","3eo8","Clostridium difficile 630","BLUB-LIKE FLAVOPROTEIN","Nitroreductase",4,"LEU A 150-LEU A 765;ALA A 152-ALA A 767;ILE A 153-ILE A 768;ILE A 7-ILE A 824","None","0.61A","NA","19.54"],["1TBF_A_VIAA501_1","3dds","Homo sapiens","GLYCOGEN PHOSPHORYLASE, LIVER FORM","Phosphorylase",4,"LEU A 765-LEU A 725;LEU A 581-LEU A 765;ILE A 584-ILE A 768;ILE A 742-ILE A 824","None","0.61A","NA","17.65"],["1TBF_A_VIAA501_1","4c91","Bacteroides ovatus","ALPHA-GLUCURONIDASE GH115","GH115_C;Glyco_hydro_115",4,"LEU A 46-LEU A 725;LEU A 160-LEU A 765;ILE A 157-ILE A 768;ILE A 96-ILE A 824","None","0.61A","NA","15.99"],["1TBF_A_VIAA501_1","2erf","Homo sapiens","THROMBOSPONDIN-1","NA",4,"LEU A 130-LEU A 725;LEU A 149-LEU A 765;ALA A 147-ALA A 767;ILE A 138-ILE A 824","None","0.61A","NA","19.65"],["1TBF_A_VIAA501_1","2mca","Eubacterium rectale","UNCHARACTERIZED PROTEIN","DUF5300",4,"LEU A 13-LEU A 765;ILE A 45-ILE A 768;PHE A 47-PHE A 820;ILE A 11-ILE A 824","None","0.62A","NA","14.74"],["1TBF_A_VIAA501_1","5nny","Legionella pneumophila","WIPB","NA",4,"LEU A 137-LEU A 725;LEU A 44-LEU A 765;ILE A 43-ILE A 768;ILE A 113-ILE A 824","None","0.62A","NA","23.20"],["1TBF_A_VIAA501_1","3nvn","Ectromelia virus;homo sapiens","PLEXIN-C1","PSI",4,"LEU B 429-LEU A 725;LEU B 399-LEU A 765;ILE B 416-ILE A 768;ILE B 439-ILE A 824","None","0.62A","NA","20.95"],["1TBF_A_VIAA501_1","3m6i","Neurospora crassa","L-ARABINITOL 4-DEHYDROGENASE","ADH_N;ADH_zinc_N",4,"LEU A 330-LEU A 725;LEU A 197-LEU A 765;ALA A 199-ALA A 767;ILE A 223-ILE A 824","None","0.62A","NA","20.66"],["1TBF_A_VIAA501_1","2vif","Homo sapiens","SUPPRESSOR OF CYTOKINE SIGNALLING 6","SH2",4,"LEU A 487-LEU A 725;LEU A 420-LEU A 765;ILE A 433-ILE A 768;ILE A 458-ILE A 824","None","0.62A","NA","17.01"],["1TBF_A_VIAA501_1","5z2c","Homo sapiens","ALPHA-PROTEIN KINASE 1","NA",4,"LEU A 239-LEU A 725;LEU A 444-LEU A 765;ILE A 445-ILE A 768;ILE A 221-ILE A 824","None","0.62A","NA","21.78"],["1TBF_A_VIAA501_1","5tib","Escherichia coli;homo sapiens","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,GASDERMIN-B","Gasdermin_C",4,"LEU A1279-LEU A 725;LEU A1399-LEU A 765;ILE A1398-ILE A 768;PHE A1332-PHE A 820","None","0.62A","NA","22.05"],["1TBF_A_VIAA501_1","3pi7","Mesorhizobium loti","NADH OXIDOREDUCTASE","ADH_N;ADH_zinc_N",4,"LEU A 150-LEU A 765;ALA A 152-ALA A 767;ILE A 153-ILE A 768;ILE A 304-ILE A 824","None","0.62A","NA","21.39"],["1TBF_A_VIAA501_1","1gnt","Desulfovibrio vulgaris","HYBRID CLUSTER PROTEIN","Prismane",4,"LEU A 183-LEU A 725;LEU A 66-LEU A 765;ALA A 68-ALA A 767;ILE A 152-ILE A 824","None","0.63A","NA","23.05"],["1TBF_A_VIAA501_1","3sp1","Borrelia burgdorferi","CYSTEINYL-TRNA SYNTHETASE","tRNA-synt_1e",4,"LEU A 5-LEU A 725;LEU A 49-LEU A 765;ILE A 50-ILE A 768;ILE A 235-ILE A 824","None","0.63A","NA","23.31"],["1TBF_A_VIAA501_1","2wzp","Lactococcus phage p2;lama glama","LACTOCOCCAL PHAGE P2 ORF16","Caudo_bapla16",4,"ALA R 176-ALA A 767;ILE R 179-ILE A 768;PHE R 157-PHE A 820;ILE R 156-ILE A 824","None","0.63A","NA","22.14"],["1TBF_A_VIAA501_1","4zcf","Escherichia coli;synthetic construct","RESTRICTION ENDONUCLEASE ECOP15I, RESTRICTION SUBUNIT","RE_endonuc;ResIII",4,"LEU C 132-LEU A 725;LEU C 144-LEU A 765;ILE C 181-ILE A 768;PHE C 99-PHE A 820","None","0.64A","NA","16.29"],["1TBF_A_VIAA501_1","3bge","Haemophilus influenzae","PREDICTED ATPASE","MgsA_C",4,"LEU A 294-LEU A 765;ALA A 296-ALA A 767;ILE A 297-ILE A 768;ILE A 336-ILE A 824","None","0.64A","NA","19.03"],["1TBF_A_VIAA501_1","1f5n","Homo sapiens","INTERFERON-INDUCED GUANYLATE-BINDING PROTEIN 1","GBP;GBP_C",4,"LEU A 13-LEU A 725;LEU A 31-LEU A 765;ALA A 33-ALA A 767;ILE A 34-ILE A 768","None","0.64A","NA","20.10"],["1TBF_A_VIAA501_1","1nc7","Thermotoga maritima","HYPOTHETICAL PROTEIN TM1070","ASRT",4,"LEU A 68-LEU A 765;ILE A 73-ILE A 768;PHE A 44-PHE A 820;ILE A 81-ILE A 824","None","0.64A","NA","20.55"],["1TBF_A_VIAA501_1","3qok","Klebsiella pneumoniae subsp. pneumoniae","PUTATIVE CHITINASE II","Glyco_hydro_18",4,"LEU A 84-LEU A 725;LEU A 109-LEU A 765;ILE A 148-ILE A 768;ILE A 139-ILE A 824","None","0.64A","NA","23.97"],["1TBF_A_VIAA501_1","1nu4","Homo sapiens","U1A RNA BINDING DOMAIN","RRM_1",4,"LEU A 30-LEU A 765;ALA A 32-ALA A 767;ILE A 33-ILE A 768;PHE A 77-PHE A 820","None","0.64A","NA","13.51"],["1TBF_A_VIAA501_1","5kvk","Klebsiella pneumoniae 700603","PROTEIN KP700603","CinA",4,"LEU A 162-LEU A 725;LEU A 23-LEU A 765;ALA A 25-ALA A 767;ILE A 104-ILE A 824","None","0.64A","NA","18.05"],["1TBF_A_VIAA501_1","3dxq","Mesorhizobium loti","CHOLINE\/ETHANOLAMINE KINASE FAMILY PROTEIN","Choline_kinase",4,"LEU A 23-LEU A 725;LEU A 10-LEU A 765;ALA A 12-ALA A 767;ILE A 13-ILE A 768","None","0.64A","NA","21.28"],["1TBF_A_VIAA501_1","4hku","Listeria monocytogenes","TETR TRANSCRIPTIONAL REGULATOR","TetR_C_27;TetR_N",4,"LEU A 125-LEU A 765;ALA A 123-ALA A 767;PHE A 68-PHE A 820;ILE A 67-ILE A 824","None","0.64A","NA","20.83"],["1TBF_A_VIAA501_1","3kts","Listeria monocytogenes str. 4b","GLYCEROL UPTAKE OPERON ANTITERMINATOR REGULATORY PROTEIN","NA",4,"LEU A 41-LEU A 725;LEU A 57-LEU A 765;ILE A 84-ILE A 768;ILE A 79-ILE A 824","None","0.64A","NA","21.33"],["1TBF_A_VIAA501_1","5ima","Xanthomonas campestris pv. campestris (strain atcc 33913 \/ dsm 3586 \/ ncppb 528 \/ lmg 568 \/ p 25)","BACTERIOFERRITIN COMIGRATORY PROTEIN","AhpC-TSA",4,"LEU A 101-LEU A 725;LEU A 27-LEU A 765;ALA A 29-ALA A 767;ILE A 37-ILE A 824","None","0.65A","NA","18.52"],["1TBF_A_VIAA501_1","2afw","Homo sapiens","GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE","Peptidase_M28",4,"LEU A 318-LEU A 725;LEU A 271-LEU A 765;ALA A 273-ALA A 767;ILE A 274-ILE A 768","None","0.65A","NA","22.49"],["1TBF_A_VIAA501_1","4g6c","Burkholderia cenocepacia","BETA-HEXOSAMINIDASE 1","Glyco_hydro_3",4,"LEU A 197-LEU A 765;ALA A 195-ALA A 767;ILE A 196-ILE A 768;ILE A 239-ILE A 824","None","0.65A","NA","23.44"],["1TBF_A_VIAA501_1","3pih","Thermotoga maritima;synthetic construct","UVRABC SYSTEM PROTEIN A","ABC_tran;UvrA_DNA-bind;UvrA_inter",4,"LEU A 635-LEU A 725;LEU A 590-LEU A 765;ALA A 588-ALA A 767;ILE A 652-ILE A 824","None","0.65A","NA","16.68"],["1TBF_A_VIAA501_1","5ew8","Homo sapiens","FIBROBLAST GROWTH FACTOR RECEPTOR 1","PK_Tyr_Ser-Thr",4,"LEU A 465-LEU A 725;LEU A 525-LEU A 765;ALA A 520-ALA A 767;ILE A 529-ILE A 824","None","0.65A","NA","20.16"],["1TBF_A_VIAA501_1","2qq8","Homo sapiens","TBC1 DOMAIN FAMILY MEMBER 14","RabGAP-TBC",4,"LEU A 504-LEU A 765;ILE A 503-ILE A 768;PHE A 465-PHE A 820;ILE A 464-ILE A 824","None","0.65A","NA","26.35"],["1TBF_A_VIAA501_1","1xkn","Chlorobium tepidum","PUTATIVE PEPTIDYL-ARGININE DEIMINASE","PAD_porph",4,"LEU A 155-LEU A 725;LEU A 193-LEU A 765;ILE A 199-ILE A 768;ILE A 160-ILE A 824","None","0.65A","NA","22.60"],["1TBF_A_VIAA501_1","2d4a","Aeropyrum pernix","MALATE DEHYDROGENASE","Ldh_1_C;Ldh_1_N",4,"LEU B 18-LEU A 725;ALA B 235-ALA A 767;ILE B 236-ILE A 768;ILE B 2-ILE A 824","None","0.65A","NA","22.07"],["1TBF_A_VIAA501_1","4k5s","Streptomyces argillaceus","OXYGENASE","FAD_binding_3",4,"LEU A 309-LEU A 725;LEU A 117-LEU A 765;ALA A 115-ALA A 767;PHE A 73-PHE A 820","None","0.65A","NA","20.51"],["1TBF_A_VIAA501_1","3mru","Vibrio alginolyticus","AMINOACYL-HISTIDINE DIPEPTIDASE","M20_dimer;Peptidase_M20",4,"LEU A 77-LEU A 725;LEU A 483-LEU A 765;ALA A 485-ALA A 767;ILE A 141-ILE A 824","None","0.66A","NA","21.56"],["1TBF_A_VIAA501_1","5e31","Enterococcus faecium do","PENICILLIN BINDING PROTEIN 2 PRIME","MecA_N;PBP_dimer;Transpeptidase",4,"LEU A 274-LEU A 725;LEU A 568-LEU A 765;ALA A 570-ALA A 767;ILE A 569-ILE A 768","None","0.66A","NA","20.34"],["1TBF_A_VIAA501_1","4y4q","Streptococcus pneumoniae pcs8235","SORTASE, SRTB FAMILY","Sortase",4,"LEU A 238-LEU A 765;ALA A 254-ALA A 767;ILE A 236-ILE A 768;ILE A 127-ILE A 824","None","0.66A","NA","20.96"],["1TBF_A_VIAA501_1","3zvk","Rickettsia felis;synthetic construct","TOXIN OF TOXIN-ANTITOXIN SYSTEM","PIN",4,"LEU A 25-LEU A 725;LEU A 5-LEU A 765;ILE A 36-ILE A 768;ILE A 34-ILE A 824","None","0.67A","NA","16.18"],["1TBF_A_VIAA501_1","5yjd","Staphylococcus epidermidis rp62a","CSM3","RAMPs",4,"LEU A 96-LEU A 725;ILE A 199-ILE A 768;PHE A 166-PHE A 820;ILE A 169-ILE A 824","None; CA A 301 (-4.9A);None;None","0.67A","NA","19.94"],["1TBF_A_VIAA501_1","1r7j","Sulfolobus solfataricus","CONSERVED HYPOTHETICAL PROTEIN SSO10A","HTH_45",4,"LEU A 14-LEU A 765;ALA A 12-ALA A 767;ILE A 13-ILE A 768;ILE A 49-ILE A 824","None","0.67A","NA","16.50"],["1TBF_A_VIAA501_1","3rl5","Rattus norvegicus","METALLOPHOSPHOESTERASE MPPED2","Metallophos",4,"LEU A 162-LEU A 765;ALA A 177-ALA A 767;ILE A 114-ILE A 768;ILE A 112-ILE A 824","None","0.67A","NA","21.95"]]

List of all similar binding patterns of amino acids (1TBF_A_VIAA501_0, 10 residues)

Note that only 3-12 residue patterns can be used for ASSAM searches, thus the binding sites are divided into fragments. Hit pattern: 3D amino acid arrangements similar to known drug binding site Query pattern: Residues from known binding site for annotated drug that match the hit pattern (Click on the 'View' column to view superposed patterns of amino acids - Superposition on full binding site) (Click the 'Script' button to download a python script for molecular docking in UCSF Chimera)

	Hit	Macromolecule/ Organism	Pfam	Res.	Residue Matches	HETATM Residue/s	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5jo3	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	10	TYR B 612 - TYR A 612 HIS B 613 - HIS A 613 ALA B 779 - ALA A 779 VAL B 782 - VAL A 782 ALA B 783 - ALA A 783 PHE B 786 - PHE A 786 LEU B 804 - LEU A 804 ILE B 813 - ILE A 813 MET B 816 - MET A 816 GLN B 817 - GLN A 817	None ZN  B 901 ( 4.9A) 6LK  B 903 (-3.7A) 6LK  B 903 ( 4.9A) None None 6LK  B 903 (-4.0A) None 6LK  B 903 (-4.0A) 6LK  B 903 (-3.3A)	0.51A	54.3	99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1tbf	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	9	TYR A 612 - TYR A 612 HIS A 613 - HIS A 613 ALA A 779 - ALA A 779 VAL A 782 - VAL A 782 ALA A 783 - ALA A 783 PHE A 786 - PHE A 786 LEU A 804 - LEU A 804 ILE A 813 - ILE A 813 GLN A 817 - GLN A 817	None None VIA  A 501 (-4.6A) VIA  A 501 ( 4.6A) VIA  A 501 ( 3.9A) VIA  A 501 (-4.9A) VIA  A 501 (-4.4A) VIA  A 501 ( 4.6A) VIA  A 501 (-3.0A)	0.04A	57.9	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	7jsn	ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT BETA (Bos taurus)	GAF PDEase_I	7	TYR B 556 - TYR A 612 HIS B 557 - HIS A 613 ALA B 733 - ALA A 779 VAL B 736 - VAL A 782 ALA B 737 - ALA A 783 PHE B 740 - PHE A 786 GLN B 771 - GLN A 817	None None None VDN  B 904 ( 4.8A) VDN  B 904 ( 4.1A) None VDN  B 904 ( 3.0A)	0.50A	38.4	20.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1tbf	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	7	TYR A 612 - TYR A 612 HIS A 613 - HIS A 613 VAL A 782 - VAL A 782 PHE A 786 - PHE A 786 LEU A 804 - LEU A 804 MET A 816 - MET A 816 GLN A 817 - GLN A 817	None None VIA  A 501 ( 4.6A) VIA  A 501 (-4.9A) VIA  A 501 (-4.4A) VIA  A 501 ( 4.3A) VIA  A 501 (-3.0A)	0.61A	57.9	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5u00	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	6	TYR A 655 - TYR A 612 HIS A 656 - HIS A 613 ALA A 823 - ALA A 779 PHE A 830 - PHE A 786 ILE A 855 - ILE A 813 GLN A 859 - GLN A 817	None 7OV  A1001 (-4.0A) None 7OV  A1001 (-4.3A) None 7OV  A1001 (-3.1A)	0.40A	44.3	36.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6cyc	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	6	TYR A 655 - TYR A 612 HIS A 656 - HIS A 613 ALA A 823 - ALA A 779 PHE A 830 - PHE A 786 ILE A 855 - ILE A 813 GLN A 859 - GLN A 817	FKJ  A1003 (-4.7A) FKJ  A1003 (-4.6A) None EDO  A1005 ( 3.8A) None FKJ  A1003 (-3.0A)	0.47A	43.4	35.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	7jsn	ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA (Bos taurus)	GAF PDEase_I	6	TYR A 558 - TYR A 612 HIS A 559 - HIS A 613 ALA A 735 - ALA A 779 VAL A 738 - VAL A 782 ALA A 739 - ALA A 783 PHE A 742 - PHE A 786	None None None None VDN  A 904 ( 3.9A) None	0.51A	23.1	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1zkl	HIGH-AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A (Homo sapiens)	PDEase_I	6	TYR A 211 - TYR A 612 HIS A 212 - HIS A 613 VAL A 380 - VAL A 782 PHE A 384 - PHE A 786 ILE A 409 - ILE A 813 GLN A 413 - GLN A 817	IBM  A 503 (-4.6A) None IBM  A 503 (-4.7A) IBM  A 503 (-4.5A) None IBM  A 503 (-3.0A)	0.51A	38.5	29.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2r8q	CLASS I PHOSPHODIESTERASE PDEB1 (Leishmania major)	PDEase_I	6	TYR A 680 - TYR A 612 HIS A 681 - HIS A 613 ALA A 850 - ALA A 779 VAL A 853 - VAL A 782 PHE A 857 - PHE A 786 GLN A 887 - GLN A 817	IBM  A   3 ( 4.7A) IBM  A   3 ( 4.8A) None IBM  A   3 ( 4.8A) IBM  A   3 (-4.9A) IBM  A   3 (-3.3A)	0.51A	40.8	31.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6fe3	PHOSPHODIESTERASE (Trypanosoma brucei)	PDEase_I	6	TYR A 668 - TYR A 612 HIS A 669 - HIS A 613 ALA A 837 - ALA A 779 VAL A 840 - VAL A 782 PHE A 844 - PHE A 786 GLN A 874 - GLN A 817	None None D68  A1003 (-4.0A) D68  A1003 (-4.9A) D68  A1003 (-4.9A) D68  A1003 (-3.2A)	0.63A	39.9	31.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5h2q	PHOSPHODIESTERASE (Trypanosoma brucei brucei)	PDEase_I	5	TYR A 668 - TYR A 612 HIS A 669 - HIS A 613 ALA A 838 - ALA A 779 VAL A 841 - VAL A 782 PHE A 845 - PHE A 786	LLI  A1003 ( 4.9A) None LLI  A1003 ( 4.3A) LLI  A1003 (-4.6A) LLI  A1003 (-4.6A)	0.36A	40.9	33.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ecm	HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A (Homo sapiens)	PDEase_I	5	TYR A 555 - TYR A 612 HIS A 556 - HIS A 613 ALA A 741 - ALA A 779 ILE A 774 - ILE A 813 GLN A 778 - GLN A 817	None	0.43A	38.4	27.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5h2q	PHOSPHODIESTERASE (Trypanosoma brucei brucei)	PDEase_I	5	TYR A 668 - TYR A 612 HIS A 669 - HIS A 613 ALA A 838 - ALA A 779 VAL A 841 - VAL A 782 GLN A 875 - GLN A 817	LLI  A1003 ( 4.9A) None LLI  A1003 ( 4.3A) LLI  A1003 (-4.6A) LLI  A1003 (-3.1A)	0.54A	40.9	33.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	7jsn	ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA (Bos taurus)	GAF PDEase_I	5	HIS A 559 - HIS A 613 ALA A 735 - ALA A 779 VAL A 738 - VAL A 782 ALA A 739 - ALA A 783 GLN A 773 - GLN A 817	None None None VDN  A 904 ( 3.9A) VDN  A 904 ( 3.3A)	0.59A	23.1	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3so6	LDL RECEPTOR ADAPTOR PROTEIN (Rattus norvegicus; synthetic construct)	PID	5	ALA A 163 - ALA A 779 VAL A 166 - VAL A 782 ALA A 167 - ALA A 783 PHE A 170 - PHE A 786 ILE A 112 - ILE A 813	None	0.62A	NA	20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1zkl	HIGH-AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A (Homo sapiens)	PDEase_I	5	HIS A 212 - HIS A 613 VAL A 380 - VAL A 782 PHE A 384 - PHE A 786 LEU A 401 - LEU A 804 GLN A 413 - GLN A 817	None IBM  A 503 (-4.7A) IBM  A 503 (-4.5A) None IBM  A 503 (-3.0A)	0.73A	38.5	29.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2dfa	HYPOTHETICAL UPF0271 PROTEIN TTHB195 (Thermus thermophilus)	LamB_YcsF	5	ALA A 229 - ALA A 779 VAL A 232 - VAL A 782 ALA A 233 - ALA A 783 LEU A 5 - LEU A 804 ILE A 24 - ILE A 813	None	0.94A	NA	20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4uej	GALACTITOL-1-PHOSPHATE 5-DEHYDROGENASE (Escherichia coli)	ADH_N ADH_zinc_N	5	ALA A 250 - ALA A 779 VAL A 247 - VAL A 782 ALA A 246 - ALA A 783 LEU A 258 - LEU A 804 ILE A 233 - ILE A 813	None	0.95A	NA	22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5oes	GLUTATHIONE SYNTHETASE (Solanum tuberosum)	GSH_synth_ATP GSH_synthase	5	ALA A 77 - ALA A 779 VAL A 80 - VAL A 782 ALA A 81 - ALA A 783 PHE A 84 - PHE A 786 LEU A 154 - LEU A 804	None	1.01A	NA	21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5oes	GLUTATHIONE SYNTHETASE (Solanum tuberosum)	GSH_synth_ATP GSH_synthase	5	VAL A 80 - VAL A 782 ALA A 81 - ALA A 783 PHE A 84 - PHE A 786 LEU A 154 - LEU A 804 ILE A 437 - ILE A 813	None	1.05A	NA	21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ft4	DNA (CYTOSINE-5)-METHYLTRANSFERASE 1 (Zea mays; synthetic construct)	BAH Chromo DNA_methylase	5	TYR B 597 - TYR A 612 ALA B 854 - ALA A 779 VAL B 857 - VAL A 782 ALA B 858 - ALA A 783 LEU B 557 - LEU A 804	None	1.18A	NA	18.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3k11	PUTATIVE GLYCOSYL HYDROLASE (Bacteroides thetaiotaomicron vpi-5482)	Glyco_hydro_88	5	TYR A 83 - TYR A 612 VAL A 137 - VAL A 782 ALA A 138 - ALA A 783 PHE A 141 - PHE A 786 ILE A 158 - ILE A 813	None	1.20A	NA	20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ocd	L-ASPARAGINASE I (Vibrio cholerae)	Asparaginase Asparaginase_C	5	VAL A 205 - VAL A 782 PHE A 105 - PHE A 786 LEU A 101 - LEU A 804 ILE A 208 - ILE A 813 GLN A 69 - GLN A 817	None	1.22A	NA	21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4i9f	GLYCEROL 3-PHOSPHATE PHOSPHATASE (Mycobacterium tuberculosis)	GNAT_like Hydrolase_6 Hydrolase_like	5	TYR A 240 - TYR A 612 ALA A 306 - ALA A 779 VAL A 239 - VAL A 782 ALA A 238 - ALA A 783 ILE A 250 - ILE A 813	None	1.23A	NA	20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6sfw	ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUBUNIT CLPX (Listeria monocytogenes)	AAA_2 ClpB_D2-small zf-C4_ClpX	5	TYR O 93 - TYR A 612 ALA O 88 - ALA A 779 VAL O 89 - VAL A 782 ALA O 86 - ALA A 783 LEU O 71 - LEU A 804	None	1.25A	NA	23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6pux	HOMOSERINE O-ACETYLTRANSFERASE (Mycobacterium tuberculosis (strain atcc 25618 / h37rv))	Abhydrolase_1	5	ALA A 97 - ALA A 779 VAL A 98 - VAL A 782 ALA A 99 - ALA A 783 LEU A 57 - LEU A 804 ILE A 66 - ILE A 813	None	1.25A	NA	22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3qan	1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE 1 (Bacillus halodurans)	Aldedh	5	VAL A 422 - VAL A 782 ALA A 423 - ALA A 783 PHE A 424 - PHE A 786 LEU A 337 - LEU A 804 MET A 385 - MET A 816	None	1.26A	NA	20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3jxv	70 KDA PEPTIDYL-PROLYL ISOMERASE (Triticum aestivum)	FKBP_C	5	HIS A 207 - HIS A 613 ALA A 215 - ALA A 779 ALA A 211 - ALA A 783 LEU A 255 - LEU A 804 ILE A 159 - ILE A 813	None	1.31A	NA	20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4qaw	XYN30D (Paenibacillus barcinonensis)	CBM_6	5	TYR A 54 - TYR A 612 HIS A 23 - HIS A 613 ALA A 81 - ALA A 783 ILE A 133 - ILE A 813 MET A 170 - MET A 816	None	1.32A	NA	18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ddj	CBS DOMAIN-CONTAINING PROTEIN (Sulfolobus solfataricus)	CBS	5	ALA A 196 - ALA A 779 VAL A 197 - VAL A 782 ALA A 194 - ALA A 783 PHE A 24 - PHE A 786 LEU A 51 - LEU A 804	None	1.42A	NA	24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3cwn	TRANSALDOLASE B (Escherichia coli)	TAL_FSA	5	TYR A 218 - TYR A 612 ALA A 170 - ALA A 779 ALA A 166 - ALA A 783 LEU A 158 - LEU A 804 ILE A 140 - ILE A 813	None	1.43A	NA	26.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2e1d	TRANSALDOLASE (Mus musculus)	TAL_FSA	5	TYR A 229 - TYR A 612 ALA A 181 - ALA A 779 ALA A 177 - ALA A 783 LEU A 169 - LEU A 804 ILE A 150 - ILE A 813	None	1.46A	NA	23.12
	Hit	Macromolecule/ Organism	Pfam	Res.	Residue Matches	HETATM Residue/s	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock

[["1TBF_A_VIAA501_0","5jo3","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",10,"TYR B 612-TYR A 612;HIS B 613-HIS A 613;ALA B 779-ALA A 779;VAL B 782-VAL A 782;ALA B 783-ALA A 783;PHE B 786-PHE A 786;LEU B 804-LEU A 804;ILE B 813-ILE A 813;MET B 816-MET A 816;GLN B 817-GLN A 817","None; ZN B 901 ( 4.9A);6LK B 903 (-3.7A);6LK B 903 ( 4.9A);None;None;6LK B 903 (-4.0A);None;6LK B 903 (-4.0A);6LK B 903 (-3.3A)","0.51A","54.3","99.69"],["1TBF_A_VIAA501_0","1tbf","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",9,"TYR A 612-TYR A 612;HIS A 613-HIS A 613;ALA A 779-ALA A 779;VAL A 782-VAL A 782;ALA A 783-ALA A 783;PHE A 786-PHE A 786;LEU A 804-LEU A 804;ILE A 813-ILE A 813;GLN A 817-GLN A 817","None;None;VIA A 501 (-4.6A);VIA A 501 ( 4.6A);VIA A 501 ( 3.9A);VIA A 501 (-4.9A);VIA A 501 (-4.4A);VIA A 501 ( 4.6A);VIA A 501 (-3.0A)","0.04A","57.9","100.00"],["1TBF_A_VIAA501_0","7jsn","Bos taurus","ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT BETA","GAF;PDEase_I",7,"TYR B 556-TYR A 612;HIS B 557-HIS A 613;ALA B 733-ALA A 779;VAL B 736-VAL A 782;ALA B 737-ALA A 783;PHE B 740-PHE A 786;GLN B 771-GLN A 817","None;None;None;VDN B 904 ( 4.8A);VDN B 904 ( 4.1A);None;VDN B 904 ( 3.0A)","0.50A","38.4","20.05"],["1TBF_A_VIAA501_0","1tbf","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",7,"TYR A 612-TYR A 612;HIS A 613-HIS A 613;VAL A 782-VAL A 782;PHE A 786-PHE A 786;LEU A 804-LEU A 804;MET A 816-MET A 816;GLN A 817-GLN A 817","None;None;VIA A 501 ( 4.6A);VIA A 501 (-4.9A);VIA A 501 (-4.4A);VIA A 501 ( 4.3A);VIA A 501 (-3.0A)","0.61A","57.9","100.00"],["1TBF_A_VIAA501_0","5u00","Homo sapiens","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",6,"TYR A 655-TYR A 612;HIS A 656-HIS A 613;ALA A 823-ALA A 779;PHE A 830-PHE A 786;ILE A 855-ILE A 813;GLN A 859-GLN A 817","None;7OV A1001 (-4.0A);None;7OV A1001 (-4.3A);None;7OV A1001 (-3.1A)","0.40A","44.3","36.09"],["1TBF_A_VIAA501_0","6cyc","Homo sapiens","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",6,"TYR A 655-TYR A 612;HIS A 656-HIS A 613;ALA A 823-ALA A 779;PHE A 830-PHE A 786;ILE A 855-ILE A 813;GLN A 859-GLN A 817","FKJ A1003 (-4.7A);FKJ A1003 (-4.6A);None;EDO A1005 ( 3.8A);None;FKJ A1003 (-3.0A)","0.47A","43.4","35.19"],["1TBF_A_VIAA501_0","7jsn","Bos taurus","ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA","GAF;PDEase_I",6,"TYR A 558-TYR A 612;HIS A 559-HIS A 613;ALA A 735-ALA A 779;VAL A 738-VAL A 782;ALA A 739-ALA A 783;PHE A 742-PHE A 786","None;None;None;None;VDN A 904 ( 3.9A);None","0.51A","23.1","20.00"],["1TBF_A_VIAA501_0","1zkl","Homo sapiens","HIGH-AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A","PDEase_I",6,"TYR A 211-TYR A 612;HIS A 212-HIS A 613;VAL A 380-VAL A 782;PHE A 384-PHE A 786;ILE A 409-ILE A 813;GLN A 413-GLN A 817","IBM A 503 (-4.6A);None;IBM A 503 (-4.7A);IBM A 503 (-4.5A);None;IBM A 503 (-3.0A)","0.51A","38.5","29.52"],["1TBF_A_VIAA501_0","2r8q","Leishmania major","CLASS I PHOSPHODIESTERASE PDEB1","PDEase_I",6,"TYR A 680-TYR A 612;HIS A 681-HIS A 613;ALA A 850-ALA A 779;VAL A 853-VAL A 782;PHE A 857-PHE A 786;GLN A 887-GLN A 817","IBM A 3 ( 4.7A);IBM A 3 ( 4.8A);None;IBM A 3 ( 4.8A);IBM A 3 (-4.9A);IBM A 3 (-3.3A)","0.51A","40.8","31.69"],["1TBF_A_VIAA501_0","6fe3","Trypanosoma brucei","PHOSPHODIESTERASE","PDEase_I",6,"TYR A 668-TYR A 612;HIS A 669-HIS A 613;ALA A 837-ALA A 779;VAL A 840-VAL A 782;PHE A 844-PHE A 786;GLN A 874-GLN A 817","None;None;D68 A1003 (-4.0A);D68 A1003 (-4.9A);D68 A1003 (-4.9A);D68 A1003 (-3.2A)","0.63A","39.9","31.65"],["1TBF_A_VIAA501_0","5h2q","Trypanosoma brucei brucei","PHOSPHODIESTERASE","PDEase_I",5,"TYR A 668-TYR A 612;HIS A 669-HIS A 613;ALA A 838-ALA A 779;VAL A 841-VAL A 782;PHE A 845-PHE A 786","LLI A1003 ( 4.9A);None;LLI A1003 ( 4.3A);LLI A1003 (-4.6A);LLI A1003 (-4.6A)","0.36A","40.9","33.71"],["1TBF_A_VIAA501_0","3ecm","Homo sapiens","HIGH AFFINITY CAMP-SPECIFIC AND IBMX-INSENSITIVE 3',5'-CYCLIC PHOSPHODIESTERASE 8A","PDEase_I",5,"TYR A 555-TYR A 612;HIS A 556-HIS A 613;ALA A 741-ALA A 779;ILE A 774-ILE A 813;GLN A 778-GLN A 817","None","0.43A","38.4","27.30"],["1TBF_A_VIAA501_0","5h2q","Trypanosoma brucei brucei","PHOSPHODIESTERASE","PDEase_I",5,"TYR A 668-TYR A 612;HIS A 669-HIS A 613;ALA A 838-ALA A 779;VAL A 841-VAL A 782;GLN A 875-GLN A 817","LLI A1003 ( 4.9A);None;LLI A1003 ( 4.3A);LLI A1003 (-4.6A);LLI A1003 (-3.1A)","0.54A","40.9","33.71"],["1TBF_A_VIAA501_0","7jsn","Bos taurus","ROD CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA","GAF;PDEase_I",5,"HIS A 559-HIS A 613;ALA A 735-ALA A 779;VAL A 738-VAL A 782;ALA A 739-ALA A 783;GLN A 773-GLN A 817","None;None;None;VDN A 904 ( 3.9A);VDN A 904 ( 3.3A)","0.59A","23.1","20.00"],["1TBF_A_VIAA501_0","3so6","Rattus norvegicus;synthetic construct","LDL RECEPTOR ADAPTOR PROTEIN","PID",5,"ALA A 163-ALA A 779;VAL A 166-VAL A 782;ALA A 167-ALA A 783;PHE A 170-PHE A 786;ILE A 112-ILE A 813","None","0.62A","NA","20.06"],["1TBF_A_VIAA501_0","1zkl","Homo sapiens","HIGH-AFFINITY CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 7A","PDEase_I",5,"HIS A 212-HIS A 613;VAL A 380-VAL A 782;PHE A 384-PHE A 786;LEU A 401-LEU A 804;GLN A 413-GLN A 817","None;IBM A 503 (-4.7A);IBM A 503 (-4.5A);None;IBM A 503 (-3.0A)","0.73A","38.5","29.52"],["1TBF_A_VIAA501_0","2dfa","Thermus thermophilus","HYPOTHETICAL UPF0271 PROTEIN TTHB195","LamB_YcsF",5,"ALA A 229-ALA A 779;VAL A 232-VAL A 782;ALA A 233-ALA A 783;LEU A 5-LEU A 804;ILE A 24-ILE A 813","None","0.94A","NA","20.22"],["1TBF_A_VIAA501_0","4uej","Escherichia coli","GALACTITOL-1-PHOSPHATE 5-DEHYDROGENASE","ADH_N;ADH_zinc_N",5,"ALA A 250-ALA A 779;VAL A 247-VAL A 782;ALA A 246-ALA A 783;LEU A 258-LEU A 804;ILE A 233-ILE A 813","None","0.95A","NA","22.04"],["1TBF_A_VIAA501_0","5oes","Solanum tuberosum","GLUTATHIONE SYNTHETASE","GSH_synth_ATP;GSH_synthase",5,"ALA A 77-ALA A 779;VAL A 80-VAL A 782;ALA A 81-ALA A 783;PHE A 84-PHE A 786;LEU A 154-LEU A 804","None","1.01A","NA","21.50"],["1TBF_A_VIAA501_0","5oes","Solanum tuberosum","GLUTATHIONE SYNTHETASE","GSH_synth_ATP;GSH_synthase",5,"VAL A 80-VAL A 782;ALA A 81-ALA A 783;PHE A 84-PHE A 786;LEU A 154-LEU A 804;ILE A 437-ILE A 813","None","1.05A","NA","21.50"],["1TBF_A_VIAA501_0","4ft4","Zea mays;synthetic construct","DNA (CYTOSINE-5)-METHYLTRANSFERASE 1","BAH;Chromo;DNA_methylase",5,"TYR B 597-TYR A 612;ALA B 854-ALA A 779;VAL B 857-VAL A 782;ALA B 858-ALA A 783;LEU B 557-LEU A 804","None","1.18A","NA","18.17"],["1TBF_A_VIAA501_0","3k11","Bacteroides thetaiotaomicron vpi-5482","PUTATIVE GLYCOSYL HYDROLASE","Glyco_hydro_88",5,"TYR A 83-TYR A 612;VAL A 137-VAL A 782;ALA A 138-ALA A 783;PHE A 141-PHE A 786;ILE A 158-ILE A 813","None","1.20A","NA","20.95"],["1TBF_A_VIAA501_0","2ocd","Vibrio cholerae","L-ASPARAGINASE I","Asparaginase;Asparaginase_C",5,"VAL A 205-VAL A 782;PHE A 105-PHE A 786;LEU A 101-LEU A 804;ILE A 208-ILE A 813;GLN A 69-GLN A 817","None","1.22A","NA","21.28"],["1TBF_A_VIAA501_0","4i9f","Mycobacterium tuberculosis","GLYCEROL 3-PHOSPHATE PHOSPHATASE","GNAT_like;Hydrolase_6;Hydrolase_like",5,"TYR A 240-TYR A 612;ALA A 306-ALA A 779;VAL A 239-VAL A 782;ALA A 238-ALA A 783;ILE A 250-ILE A 813","None","1.23A","NA","20.37"],["1TBF_A_VIAA501_0","6sfw","Listeria monocytogenes","ATP-DEPENDENT CLP PROTEASE ATP-BINDING SUBUNIT CLPX","AAA_2;ClpB_D2-small;zf-C4_ClpX",5,"TYR O 93-TYR A 612;ALA O 88-ALA A 779;VAL O 89-VAL A 782;ALA O 86-ALA A 783;LEU O 71-LEU A 804","None","1.25A","NA","23.52"],["1TBF_A_VIAA501_0","6pux","Mycobacterium tuberculosis (strain atcc 25618 \/ h37rv)","HOMOSERINE O-ACETYLTRANSFERASE","Abhydrolase_1",5,"ALA A 97-ALA A 779;VAL A 98-VAL A 782;ALA A 99-ALA A 783;LEU A 57-LEU A 804;ILE A 66-ILE A 813","None","1.25A","NA","22.03"],["1TBF_A_VIAA501_0","3qan","Bacillus halodurans","1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE 1","Aldedh",5,"VAL A 422-VAL A 782;ALA A 423-ALA A 783;PHE A 424-PHE A 786;LEU A 337-LEU A 804;MET A 385-MET A 816","None","1.26A","NA","20.30"],["1TBF_A_VIAA501_0","3jxv","Triticum aestivum","70 KDA PEPTIDYL-PROLYL ISOMERASE","FKBP_C",5,"HIS A 207-HIS A 613;ALA A 215-ALA A 779;ALA A 211-ALA A 783;LEU A 255-LEU A 804;ILE A 159-ILE A 813","None","1.31A","NA","20.32"],["1TBF_A_VIAA501_0","4qaw","Paenibacillus barcinonensis","XYN30D","CBM_6",5,"TYR A 54-TYR A 612;HIS A 23-HIS A 613;ALA A 81-ALA A 783;ILE A 133-ILE A 813;MET A 170-MET A 816","None","1.32A","NA","18.52"],["1TBF_A_VIAA501_0","3ddj","Sulfolobus solfataricus","CBS DOMAIN-CONTAINING PROTEIN","CBS",5,"ALA A 196-ALA A 779;VAL A 197-VAL A 782;ALA A 194-ALA A 783;PHE A 24-PHE A 786;LEU A 51-LEU A 804","None","1.42A","NA","24.10"],["1TBF_A_VIAA501_0","3cwn","Escherichia coli","TRANSALDOLASE B","TAL_FSA",5,"TYR A 218-TYR A 612;ALA A 170-ALA A 779;ALA A 166-ALA A 783;LEU A 158-LEU A 804;ILE A 140-ILE A 813","None","1.43A","NA","26.39"],["1TBF_A_VIAA501_0","2e1d","Mus musculus","TRANSALDOLASE","TAL_FSA",5,"TYR A 229-TYR A 612;ALA A 181-ALA A 779;ALA A 177-ALA A 783;LEU A 169-LEU A 804;ILE A 150-ILE A 813","None","1.46A","NA","23.12"]]

List of all similar binding patterns of amino acids (1TBF_A_VIAA501_1, 6 residues)

Note that only 3-12 residue patterns can be used for ASSAM searches, thus the binding sites are divided into fragments. Hit pattern: 3D amino acid arrangements similar to known drug binding site Query pattern: Residues from known binding site for annotated drug that match the hit pattern (Click on the 'View' column to view superposed patterns of amino acids - Superposition on full binding site) (Click the 'Script' button to download a python script for molecular docking in UCSF Chimera)

	Hit	Macromolecule/ Organism	Pfam	Res.	Residue Matches	HETATM Residue/s	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1tbf	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	6	LEU A 725 - LEU A 725 LEU A 765 - LEU A 765 ALA A 767 - ALA A 767 ILE A 768 - ILE A 768 PHE A 820 - PHE A 820 ILE A 824 - ILE A 824	None VIA  A 501 ( 4.8A) VIA  A 501 ( 4.0A) None VIA  A 501 (-3.7A) None	0.00A	57.9	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5jo3	CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	6	LEU B 725 - LEU A 725 LEU B 765 - LEU A 765 ALA B 767 - ALA A 767 ILE B 768 - ILE A 768 PHE B 820 - PHE A 820 ILE B 824 - ILE A 824	None 6LK  B 903 (-4.5A) 6LK  B 903 (-3.5A) 6LK  B 903 (-4.2A) 6LK  B 903 (-3.4A) None	0.56A	54.3	99.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ksm	ABC-TYPE SUGAR TRANSPORT SYSTEM, PERIPLASMIC COMPONENT (Hahella chejuensis)	Peripla_BP_4	5	LEU A 264 - LEU A 725 ALA A 243 - ALA A 767 ILE A 244 - ILE A 768 PHE A 255 - PHE A 820 ILE A 273 - ILE A 824	None	0.82A	NA	22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1bu8	PROTEIN (PANCREATIC LIPASE RELATED PROTEIN 2) (Rattus norvegicus)	Lipase PLAT	5	LEU A 131 - LEU A 765 ALA A 129 - ALA A 767 ILE A 128 - ILE A 768 PHE A 72 - PHE A 820 ILE A 102 - ILE A 824	None	0.87A	NA	21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6ac8	MYCOBACTERIUM SMEGMATIS MFD (Mycobacterium smegmatis mc2 155)	CarD_CdnL_TRCF DEAD Helicase_C TRCF UvrB_inter	5	LEU A 481 - LEU A 725 LEU A 16 - LEU A 765 ALA A 14 - ALA A 767 ILE A 13 - ILE A 768 ILE A 483 - ILE A 824	None None SO4  A1306 (-4.5A) None None	0.94A	NA	14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3kv0	HET-C2 (Podospora anserina)	GLTP	5	LEU A 107 - LEU A 725 LEU A 197 - LEU A 765 ILE A 193 - ILE A 768 PHE A 41 - PHE A 820 ILE A 88 - ILE A 824	None MLY  A 198 ( 4.3A) MLY  A 192 ( 4.3A) None None	0.94A	NA	23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3sxx	PEROXISOMAL PRIMARY AMINE OXIDASE (Pichia angusta)	Cu_amine_oxid Cu_amine_oxidN2 Cu_amine_oxidN3	5	LEU A 643 - LEU A 765 ALA A 418 - ALA A 767 ILE A 419 - ILE A 768 PHE A 293 - PHE A 820 ILE A 464 - ILE A 824	None	0.94A	NA	18.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4xai	MALTOSE-BINDING PERIPLASMIC PROTEIN,TAILLESS ORTHOLOG (Escherichia coli o157:h7; tribolium castaneum; synthetic construct)	SBP_bac_1	5	LEU A1292 - LEU A 725 LEU A1300 - LEU A 765 ALA A1302 - ALA A 767 ILE A1303 - ILE A 768 ILE A1358 - ILE A 824	None	0.96A	NA	22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4udq	GLUCOSE-METHANOL-CHOLINE OXIDOREDUCTASE (Methylovorus sp. mp688)	GMC_oxred_C GMC_oxred_N	5	LEU A 458 - LEU A 725 LEU A 410 - LEU A 765 ILE A 413 - ILE A 768 PHE A 368 - PHE A 820 ILE A 310 - ILE A 824	None	1.01A	NA	20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1hc7	PROLYL-TRNA SYNTHETASE (Thermus thermophilus)	HGTP_anticodon ProRS-C_1 tRNA-synt_2b	5	LEU A 285 - LEU A 725 LEU A 185 - LEU A 765 ALA A 183 - ALA A 767 PHE A 265 - PHE A 820 ILE A 50 - ILE A 824	None	1.04A	NA	21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3hjv	MALONYL COA-ACYL CARRIER PROTEIN TRANSACYLASE (Vibrio cholerae)	Acyl_transf_1	5	LEU A 118 - LEU A 725 ALA A 251 - ALA A 767 ILE A 248 - ILE A 768 PHE A 226 - PHE A 820 ILE A 110 - ILE A 824	None	1.09A	NA	20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3nrg	TETR FAMILY TRANSCRIPTIONAL REGULATOR (Chloroflexus aurantiacus)	TetR_N	5	LEU A 174 - LEU A 765 ALA A 179 - ALA A 767 ILE A 175 - ILE A 768 PHE A 102 - PHE A 820 ILE A 98 - ILE A 824	None	1.09A	NA	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2okc	TYPE I RESTRICTION ENZYME STYSJI M PROTEIN (Bacteroides thetaiotaomicron vpi-5482)	HsdM_N N6_Mtase	5	LEU A 330 - LEU A 725 LEU A 425 - LEU A 765 ILE A 427 - ILE A 768 PHE A 364 - PHE A 820 ILE A 333 - ILE A 824	None	1.11A	NA	22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4b63	L-ORNITHINE N5 MONOOXYGENASE (Aspergillus fumigatus)	K_oxygenase	5	LEU A 31 - LEU A 725 ALA A 53 - ALA A 767 ILE A 54 - ILE A 768 PHE A 81 - PHE A 820 ILE A 79 - ILE A 824	None	1.12A	NA	22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4cj0	ENDOGLUCANASE D (Clostridium thermocellum; synthetic construct)	CelD_N Dockerin_1 Glyco_hydro_9	5	LEU A 487 - LEU A 765 ALA A 489 - ALA A 767 ILE A 490 - ILE A 768 PHE A 571 - PHE A 820 ILE A 62 - ILE A 824	None	1.12A	NA	20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3si2	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE (Mus musculus)	Peptidase_M28	5	LEU A 321 - LEU A 725 LEU A 272 - LEU A 765 ALA A 274 - ALA A 767 ILE A 275 - ILE A 768 ILE A 352 - ILE A 824	None	1.22A	NA	22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3nyi	FAT ACID-BINDING PROTEIN (Eubacterium ventriosum)	DegV	5	LEU A 152 - LEU A 725 LEU A 131 - LEU A 765 ILE A 132 - ILE A 768 PHE A 87 - PHE A 820 ILE A 119 - ILE A 824	None	1.22A	NA	22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3lyk	STRINGENT STARVATION PROTEIN A HOMOLOG (Haemophilus influenzae)	GST_C	5	LEU A 165 - LEU A 725 LEU A 136 - LEU A 765 ILE A 139 - ILE A 768 PHE A 143 - PHE A 820 ILE A 183 - ILE A 824	None	1.23A	NA	20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3b8a	HEXOKINASE-1 (Saccharomyces cerevisiae)	Hexokinase_1 Hexokinase_2	5	LEU X 56 - LEU A 725 ALA X 402 - ALA A 767 ILE X 403 - ILE A 768 PHE X 240 - PHE A 820 ILE X 266 - ILE A 824	None	1.27A	NA	22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4nho	PROBABLE ATP-DEPENDENT RNA HELICASE DDX23 (Homo sapiens)	DEAD Helicase_C	5	LEU A 680 - LEU A 725 LEU A 655 - LEU A 765 ALA A 657 - ALA A 767 ILE A 658 - ILE A 768 ILE A 669 - ILE A 824	None	1.28A	NA	20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nkg	RHAMNOGALACTURONASE B (Aspergillus aculeatus)	CBM-like RhgB_N fn3_3	5	LEU A 55 - LEU A 725 LEU A 78 - LEU A 765 ALA A 99 - ALA A 767 ILE A 97 - ILE A 768 ILE A 51 - ILE A 824	None	1.29A	NA	18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3rp8	FLAVOPROTEIN MONOOXYGENASE (Klebsiella pneumoniae)	FAD_binding_3	5	LEU A 207 - LEU A 725 LEU A 252 - LEU A 765 ALA A 254 - ALA A 767 ILE A 253 - ILE A 768 PHE A 219 - PHE A 820	None	1.30A	NA	25.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3w0l	GLUCOKINASE REGULATORY PROTEIN (Xenopus laevis)	NA	5	LEU B 406 - LEU A 725 LEU B 315 - LEU A 765 ALA B 313 - ALA A 767 ILE B 312 - ILE A 768 ILE B 435 - ILE A 824	None	1.35A	NA	22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2bw3	TRANSPOSASE (Musca domestica)	DBD_Tnp_Hermes Dimer_Tnp_hAT	5	LEU A 257 - LEU A 725 LEU A 228 - LEU A 765 ALA A 230 - ALA A 767 ILE A 231 - ILE A 768 ILE A 179 - ILE A 824	None	1.37A	NA	21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2zf8	COMPONENT OF SODIUM-DRIVEN POLAR FLAGELLAR MOTOR (Vibrio alginolyticus)	MotY_N OmpA	5	LEU A 173 - LEU A 725 LEU A 181 - LEU A 765 ALA A 185 - ALA A 767 ILE A 184 - ILE A 768 ILE A 163 - ILE A 824	None	1.37A	NA	22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5i92	GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE (Pseudomonas aeruginosa)	Aminotran_3	5	LEU A 64 - LEU A 765 ALA A 406 - ALA A 767 ILE A 405 - ILE A 768 PHE A 320 - PHE A 820 ILE A 315 - ILE A 824	None	1.38A	NA	21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1fnn	CELL DIVISION CONTROL PROTEIN 6 (Pyrobaculum aerophilum)	AAA_22 Cdc6_C	5	LEU A 282 - LEU A 725 LEU A 293 - LEU A 765 ALA A 295 - ALA A 767 ILE A 296 - ILE A 768 ILE A 346 - ILE A 824	None	1.38A	NA	21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2vz8	FATTY ACID SYNTHASE (Sus scrofa)	ADH_zinc_N Acyl_transf_1 KAsynt_C_assoc KR Ketoacyl-synt_C Methyltransf_12 PP-binding PS-DH Thioesterase ketoacyl-synt	5	LEU A 404 - LEU A 725 LEU A 341 - LEU A 765 ALA A 339 - ALA A 767 ILE A 342 - ILE A 768 ILE A 6 - ILE A 824	None	1.41A	NA	8.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nu4	U1A RNA BINDING DOMAIN (Homo sapiens)	RRM_1	5	LEU A 17 - LEU A 725 LEU A 30 - LEU A 765 ALA A 32 - ALA A 767 ILE A 33 - ILE A 768 ILE A 14 - ILE A 824	None	1.41A	NA	13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4pkd	U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A,U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA (Sus scrofa; homo sapiens; synthetic construct)	RRM_1	5	LEU B 17 - LEU A 725 LEU B 30 - LEU A 765 ALA B 32 - ALA A 767 ILE B 33 - ILE A 768 ILE B 14 - ILE A 824	None	1.43A	NA	18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3w6j	SCPA (Geobacillus stearothermophilus)	NA	5	LEU A 21 - LEU A 725 LEU A 69 - LEU A 765 ALA A 71 - ALA A 767 ILE A 72 - ILE A 768 ILE A 40 - ILE A 824	None	1.44A	NA	20.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5u00	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	PDEase_I	4	LEU A 770 - LEU A 725 LEU A 809 - LEU A 765 PHE A 862 - PHE A 820 ILE A 866 - ILE A 824	None 7OV  A1001 ( 4.6A) 7OV  A1001 (-3.9A) None	0.35A	44.3	36.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2dly	FYN-RELATED KINASE (Mus musculus)	SH2	4	LEU A 106 - LEU A 725 LEU A 56 - LEU A 765 ILE A 69 - ILE A 768 PHE A 91 - PHE A 820	None	0.44A	NA	15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3i3w	PHOSPHOGLUCOSAMINE MUTASE (Francisella tularensis subsp. tularensis)	PGM_PMM_I PGM_PMM_II PGM_PMM_III PGM_PMM_IV	4	LEU A 27 - LEU A 725 LEU A 112 - LEU A 765 PHE A 5 - PHE A 820 ILE A 10 - ILE A 824	None	0.45A	NA	20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3hc7	GENE 12 PROTEIN (Mycobacterium phage d29)	Cutinase	4	LEU A 204 - LEU A 725 ALA A 221 - ALA A 767 ILE A 222 - ILE A 768 ILE A 186 - ILE A 824	None	0.46A	NA	20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3dzd	TRANSCRIPTIONAL REGULATOR (NTRC FAMILY) (Aquifex aeolicus)	Response_reg Sigma54_activat	4	LEU A 21 - LEU A 765 ILE A 20 - ILE A 768 PHE A 109 - PHE A 820 ILE A 113 - ILE A 824	None	0.49A	NA	22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2v4u	CTP SYNTHASE 2 (Homo sapiens)	GATase	4	LEU A 382 - LEU A 765 ALA A 384 - ALA A 767 ILE A 385 - ILE A 768 ILE A 407 - ILE A 824	None	0.49A	NA	25.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1co6	PROTEIN (CYTOCHROME C2) (Blastochloris viridis)	Cytochrom_C	4	LEU A 93 - LEU A 765 ILE A 94 - ILE A 768 PHE A 63 - PHE A 820 ILE A 67 - ILE A 824	None None HEC  A 108 (-4.7A) None	0.51A	NA	14.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1wqu	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES/FPS (Homo sapiens)	SH2	4	LEU A 103 - LEU A 725 LEU A 51 - LEU A 765 ILE A 64 - ILE A 768 ILE A 85 - ILE A 824	None	0.53A	NA	17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4pkd	U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A,U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA (Sus scrofa; homo sapiens; synthetic construct)	RRM_1	4	LEU B 30 - LEU A 765 ALA B 32 - ALA A 767 ILE B 33 - ILE A 768 PHE B 77 - PHE A 820	None	0.54A	NA	18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4eo9	2,3-BISPHOSPHOGLYCERATE-DEPENDENT PHOSPHOGLYCERATE MUTASE (Mycobacterium leprae)	His_Phos_1	4	LEU A 192 - LEU A 725 LEU A 9 - LEU A 765 ALA A 7 - ALA A 767 ILE A 182 - ILE A 824	None	0.56A	NA	21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5v4s	TRANSPORTER, CATION CHANNEL FAMILY / CYCLIC NUCLEOTIDE-BINDING DOMAIN MULTI-DOMAIN PROTEIN (Leptospira licerasiae serovar varillal str. var 010)	Ion_trans cNMP_binding	4	LEU A 133 - LEU A 725 LEU A 151 - LEU A 765 ALA A 153 - ALA A 767 ILE A 129 - ILE A 824	None	0.56A	NA	24.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4qhj	UNCHARACTERIZED PROTEIN MJ1213 (Methanocaldococcus jannaschii)	Peptidase_M56	4	LEU A 7 - LEU A 725 LEU A 55 - LEU A 765 ILE A 54 - ILE A 768 ILE A 63 - ILE A 824	None	0.56A	NA	16.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5cuw	SRTE1 (Streptomyces coelicolor (strain atcc baa-471 / a3(2) / m145))	Sortase	4	LEU A 317 - LEU A 725 LEU A 200 - LEU A 765 ALA A 198 - ALA A 767 ILE A 271 - ILE A 824	None	0.57A	NA	20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3qio	GAG-POL POLYPROTEIN,RIBONUCLEASE HI,GAG-POL POLYPROTEIN (Human immunodeficiency virus type 1 group m subtype b; escherichia coli (strain k12); human immunodeficiency virus type 1 group m subtype b (isolate hxb2))	RNase_H	4	LEU A 479 - LEU A 765 ALA A 481 - ALA A 767 ILE A 482 - ILE A 768 ILE A 505 - ILE A 824	None	0.57A	NA	17.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4v2x	ENDO-BETA-1,4-GLUCANASE (CELLULASE B) (Bacillus halodurans)	CBM46 CBM_X2 Cellulase	4	LEU A 425 - LEU A 765 ALA A 427 - ALA A 767 ILE A 428 - ILE A 768 ILE A 373 - ILE A 824	None	0.58A	NA	23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1sa3	TYPE II RESTRICTION ENZYME MSPI (Moraxella sp.; synthetic construct)	Endonuc-MspI	4	LEU A 48 - LEU A 725 LEU A 67 - LEU A 765 ALA A 69 - ALA A 767 ILE A 77 - ILE A 824	None	0.58A	NA	23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3igh	UNCHARACTERIZED METAL-DEPENDENT HYDROLASE (Pyrococcus horikoshii)	Amidohydro_3	4	LEU X 138 - LEU A 765 ALA X 140 - ALA A 767 ILE X 141 - ILE A 768 ILE X 147 - ILE A 824	None	0.58A	NA	22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4pv4	PROLINE AMINOPEPTIDASE P II (Yersinia pestis)	AMP_N Peptidase_M24	4	LEU A 323 - LEU A 725 LEU A 385 - LEU A 765 ILE A 402 - ILE A 768 ILE A 290 - ILE A 824	None	0.58A	NA	22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3cbl	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES/FPS (Homo sapiens; synthetic construct)	PK_Tyr_Ser-Thr SH2	4	LEU A 545 - LEU A 725 LEU A 493 - LEU A 765 ILE A 506 - ILE A 768 ILE A 527 - ILE A 824	None	0.58A	NA	20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ag9	FLAVODOXIN (Escherichia coli)	Flavodoxin_1	4	LEU A 52 - LEU A 725 LEU A 73 - LEU A 765 PHE A 78 - PHE A 820 ILE A 109 - ILE A 824	None	0.59A	NA	20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5h5x	PUTATIVE OXIDOREDUCTASE (Streptomyces coelicolor (strain atcc baa-471 / a3(2) / m145))	adh_short_C2	4	LEU A 140 - LEU A 765 ALA A 142 - ALA A 767 ILE A 143 - ILE A 768 ILE A 195 - ILE A 824	None	0.60A	NA	19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ci9	PROTEIN (CARBOXYLESTERASE) (Burkholderia gladioli)	Beta-lactamase	4	LEU A 302 - LEU A 725 LEU A 96 - LEU A 765 ALA A 98 - ALA A 767 ILE A 121 - ILE A 768	None	0.60A	NA	20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1otk	PHENYLACETIC ACID DEGRADATION PROTEIN PAAC (Escherichia coli)	NA	4	LEU A 5 - LEU A 725 LEU A 120 - LEU A 765 ALA A 122 - ALA A 767 ILE A 123 - ILE A 768	None	0.60A	NA	20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2v3z	XAA-PRO AMINOPEPTIDASE (Escherichia coli; synthetic construct)	AMP_N Peptidase_M24	4	LEU A 325 - LEU A 725 LEU A 386 - LEU A 765 ILE A 403 - ILE A 768 ILE A 292 - ILE A 824	None	0.60A	NA	21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3wqb	EXTRACELLULAR SERINE PROTEASE (Aeromonas sobria)	P_proprotein Peptidase_S8	4	LEU A 365 - LEU A 725 ALA A 136 - ALA A 767 ILE A 135 - ILE A 768 ILE A 417 - ILE A 824	None	0.60A	NA	21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3haz	PROLINE DEHYDROGENASE (Bradyrhizobium japonicum usda 110)	Aldedh Pro_dh Pro_dh-DNA_bdg	4	LEU A 904 - LEU A 765 ALA A 906 - ALA A 767 ILE A 907 - ILE A 768 ILE A 929 - ILE A 824	None	0.60A	NA	15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5kaz	SH2 DOMAIN-CONTAINING PROTEIN 1B (Homo sapiens)	SH2	4	LEU A 97 - LEU A 725 LEU A 42 - LEU A 765 ILE A 55 - ILE A 768 ILE A 83 - ILE A 824	None	0.61A	NA	15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4g1q	REVERSE TRANSCRIPTASE/RIBONUCLEASE H (Human immunodeficiency virus type 1)	RVT_1 RVT_connect RVT_thumb	4	LEU A 479 - LEU A 765 ALA A 481 - ALA A 767 ILE A 482 - ILE A 768 ILE A 505 - ILE A 824	None	0.61A	NA	20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3eo8	BLUB-LIKE FLAVOPROTEIN (Clostridium difficile 630)	Nitroreductase	4	LEU A 150 - LEU A 765 ALA A 152 - ALA A 767 ILE A 153 - ILE A 768 ILE A 7 - ILE A 824	None	0.61A	NA	19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3dds	GLYCOGEN PHOSPHORYLASE, LIVER FORM (Homo sapiens)	Phosphorylase	4	LEU A 765 - LEU A 725 LEU A 581 - LEU A 765 ILE A 584 - ILE A 768 ILE A 742 - ILE A 824	None	0.61A	NA	17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4c91	ALPHA-GLUCURONIDASE GH115 (Bacteroides ovatus)	GH115_C Glyco_hydro_115	4	LEU A 46 - LEU A 725 LEU A 160 - LEU A 765 ILE A 157 - ILE A 768 ILE A 96 - ILE A 824	None	0.61A	NA	15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2erf	THROMBOSPONDIN-1 (Homo sapiens)	NA	4	LEU A 130 - LEU A 725 LEU A 149 - LEU A 765 ALA A 147 - ALA A 767 ILE A 138 - ILE A 824	None	0.61A	NA	19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2mca	UNCHARACTERIZED PROTEIN (Eubacterium rectale)	DUF5300	4	LEU A 13 - LEU A 765 ILE A 45 - ILE A 768 PHE A 47 - PHE A 820 ILE A 11 - ILE A 824	None	0.62A	NA	14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5nny	WIPB (Legionella pneumophila)	NA	4	LEU A 137 - LEU A 725 LEU A 44 - LEU A 765 ILE A 43 - ILE A 768 ILE A 113 - ILE A 824	None	0.62A	NA	23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3nvn	PLEXIN-C1 (Ectromelia virus; homo sapiens)	PSI	4	LEU B 429 - LEU A 725 LEU B 399 - LEU A 765 ILE B 416 - ILE A 768 ILE B 439 - ILE A 824	None	0.62A	NA	20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3m6i	L-ARABINITOL 4-DEHYDROGENASE (Neurospora crassa)	ADH_N ADH_zinc_N	4	LEU A 330 - LEU A 725 LEU A 197 - LEU A 765 ALA A 199 - ALA A 767 ILE A 223 - ILE A 824	None	0.62A	NA	20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2vif	SUPPRESSOR OF CYTOKINE SIGNALLING 6 (Homo sapiens)	SH2	4	LEU A 487 - LEU A 725 LEU A 420 - LEU A 765 ILE A 433 - ILE A 768 ILE A 458 - ILE A 824	None	0.62A	NA	17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5z2c	ALPHA-PROTEIN KINASE 1 (Homo sapiens)	NA	4	LEU A 239 - LEU A 725 LEU A 444 - LEU A 765 ILE A 445 - ILE A 768 ILE A 221 - ILE A 824	None	0.62A	NA	21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5tib	SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,GASDERMIN-B (Escherichia coli; homo sapiens)	Gasdermin_C	4	LEU A1279 - LEU A 725 LEU A1399 - LEU A 765 ILE A1398 - ILE A 768 PHE A1332 - PHE A 820	None	0.62A	NA	22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3pi7	NADH OXIDOREDUCTASE (Mesorhizobium loti)	ADH_N ADH_zinc_N	4	LEU A 150 - LEU A 765 ALA A 152 - ALA A 767 ILE A 153 - ILE A 768 ILE A 304 - ILE A 824	None	0.62A	NA	21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1gnt	HYBRID CLUSTER PROTEIN (Desulfovibrio vulgaris)	Prismane	4	LEU A 183 - LEU A 725 LEU A 66 - LEU A 765 ALA A 68 - ALA A 767 ILE A 152 - ILE A 824	None	0.63A	NA	23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3sp1	CYSTEINYL-TRNA SYNTHETASE (Borrelia burgdorferi)	tRNA-synt_1e	4	LEU A 5 - LEU A 725 LEU A 49 - LEU A 765 ILE A 50 - ILE A 768 ILE A 235 - ILE A 824	None	0.63A	NA	23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2wzp	LACTOCOCCAL PHAGE P2 ORF16 (Lactococcus phage p2; lama glama)	Caudo_bapla16	4	ALA R 176 - ALA A 767 ILE R 179 - ILE A 768 PHE R 157 - PHE A 820 ILE R 156 - ILE A 824	None	0.63A	NA	22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4zcf	RESTRICTION ENDONUCLEASE ECOP15I, RESTRICTION SUBUNIT (Escherichia coli; synthetic construct)	RE_endonuc ResIII	4	LEU C 132 - LEU A 725 LEU C 144 - LEU A 765 ILE C 181 - ILE A 768 PHE C 99 - PHE A 820	None	0.64A	NA	16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3bge	PREDICTED ATPASE (Haemophilus influenzae)	MgsA_C	4	LEU A 294 - LEU A 765 ALA A 296 - ALA A 767 ILE A 297 - ILE A 768 ILE A 336 - ILE A 824	None	0.64A	NA	19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1f5n	INTERFERON-INDUCED GUANYLATE-BINDING PROTEIN 1 (Homo sapiens)	GBP GBP_C	4	LEU A 13 - LEU A 725 LEU A 31 - LEU A 765 ALA A 33 - ALA A 767 ILE A 34 - ILE A 768	None	0.64A	NA	20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nc7	HYPOTHETICAL PROTEIN TM1070 (Thermotoga maritima)	ASRT	4	LEU A 68 - LEU A 765 ILE A 73 - ILE A 768 PHE A 44 - PHE A 820 ILE A 81 - ILE A 824	None	0.64A	NA	20.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3qok	PUTATIVE CHITINASE II (Klebsiella pneumoniae subsp. pneumoniae)	Glyco_hydro_18	4	LEU A 84 - LEU A 725 LEU A 109 - LEU A 765 ILE A 148 - ILE A 768 ILE A 139 - ILE A 824	None	0.64A	NA	23.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nu4	U1A RNA BINDING DOMAIN (Homo sapiens)	RRM_1	4	LEU A 30 - LEU A 765 ALA A 32 - ALA A 767 ILE A 33 - ILE A 768 PHE A 77 - PHE A 820	None	0.64A	NA	13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5kvk	PROTEIN KP700603 (Klebsiella pneumoniae 700603)	CinA	4	LEU A 162 - LEU A 725 LEU A 23 - LEU A 765 ALA A 25 - ALA A 767 ILE A 104 - ILE A 824	None	0.64A	NA	18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3dxq	CHOLINE/ETHANOLAMINE KINASE FAMILY PROTEIN (Mesorhizobium loti)	Choline_kinase	4	LEU A 23 - LEU A 725 LEU A 10 - LEU A 765 ALA A 12 - ALA A 767 ILE A 13 - ILE A 768	None	0.64A	NA	21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4hku	TETR TRANSCRIPTIONAL REGULATOR (Listeria monocytogenes)	TetR_C_27 TetR_N	4	LEU A 125 - LEU A 765 ALA A 123 - ALA A 767 PHE A 68 - PHE A 820 ILE A 67 - ILE A 824	None	0.64A	NA	20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3kts	GLYCEROL UPTAKE OPERON ANTITERMINATOR REGULATORY PROTEIN (Listeria monocytogenes str. 4b)	NA	4	LEU A 41 - LEU A 725 LEU A 57 - LEU A 765 ILE A 84 - ILE A 768 ILE A 79 - ILE A 824	None	0.64A	NA	21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ima	BACTERIOFERRITIN COMIGRATORY PROTEIN (Xanthomonas campestris pv. campestris (strain atcc 33913 / dsm 3586 / ncppb 528 / lmg 568 / p 25))	AhpC-TSA	4	LEU A 101 - LEU A 725 LEU A 27 - LEU A 765 ALA A 29 - ALA A 767 ILE A 37 - ILE A 824	None	0.65A	NA	18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2afw	GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE (Homo sapiens)	Peptidase_M28	4	LEU A 318 - LEU A 725 LEU A 271 - LEU A 765 ALA A 273 - ALA A 767 ILE A 274 - ILE A 768	None	0.65A	NA	22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4g6c	BETA-HEXOSAMINIDASE 1 (Burkholderia cenocepacia)	Glyco_hydro_3	4	LEU A 197 - LEU A 765 ALA A 195 - ALA A 767 ILE A 196 - ILE A 768 ILE A 239 - ILE A 824	None	0.65A	NA	23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3pih	UVRABC SYSTEM PROTEIN A (Thermotoga maritima; synthetic construct)	ABC_tran UvrA_DNA-bind UvrA_inter	4	LEU A 635 - LEU A 725 LEU A 590 - LEU A 765 ALA A 588 - ALA A 767 ILE A 652 - ILE A 824	None	0.65A	NA	16.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ew8	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	PK_Tyr_Ser-Thr	4	LEU A 465 - LEU A 725 LEU A 525 - LEU A 765 ALA A 520 - ALA A 767 ILE A 529 - ILE A 824	None	0.65A	NA	20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2qq8	TBC1 DOMAIN FAMILY MEMBER 14 (Homo sapiens)	RabGAP-TBC	4	LEU A 504 - LEU A 765 ILE A 503 - ILE A 768 PHE A 465 - PHE A 820 ILE A 464 - ILE A 824	None	0.65A	NA	26.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1xkn	PUTATIVE PEPTIDYL-ARGININE DEIMINASE (Chlorobium tepidum)	PAD_porph	4	LEU A 155 - LEU A 725 LEU A 193 - LEU A 765 ILE A 199 - ILE A 768 ILE A 160 - ILE A 824	None	0.65A	NA	22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2d4a	MALATE DEHYDROGENASE (Aeropyrum pernix)	Ldh_1_C Ldh_1_N	4	LEU B 18 - LEU A 725 ALA B 235 - ALA A 767 ILE B 236 - ILE A 768 ILE B 2 - ILE A 824	None	0.65A	NA	22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4k5s	OXYGENASE (Streptomyces argillaceus)	FAD_binding_3	4	LEU A 309 - LEU A 725 LEU A 117 - LEU A 765 ALA A 115 - ALA A 767 PHE A 73 - PHE A 820	None	0.65A	NA	20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3mru	AMINOACYL-HISTIDINE DIPEPTIDASE (Vibrio alginolyticus)	M20_dimer Peptidase_M20	4	LEU A 77 - LEU A 725 LEU A 483 - LEU A 765 ALA A 485 - ALA A 767 ILE A 141 - ILE A 824	None	0.66A	NA	21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5e31	PENICILLIN BINDING PROTEIN 2 PRIME (Enterococcus faecium do)	MecA_N PBP_dimer Transpeptidase	4	LEU A 274 - LEU A 725 LEU A 568 - LEU A 765 ALA A 570 - ALA A 767 ILE A 569 - ILE A 768	None	0.66A	NA	20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4y4q	SORTASE, SRTB FAMILY (Streptococcus pneumoniae pcs8235)	Sortase	4	LEU A 238 - LEU A 765 ALA A 254 - ALA A 767 ILE A 236 - ILE A 768 ILE A 127 - ILE A 824	None	0.66A	NA	20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3zvk	TOXIN OF TOXIN-ANTITOXIN SYSTEM (Rickettsia felis; synthetic construct)	PIN	4	LEU A 25 - LEU A 725 LEU A 5 - LEU A 765 ILE A 36 - ILE A 768 ILE A 34 - ILE A 824	None	0.67A	NA	16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5yjd	CSM3 (Staphylococcus epidermidis rp62a)	RAMPs	4	LEU A 96 - LEU A 725 ILE A 199 - ILE A 768 PHE A 166 - PHE A 820 ILE A 169 - ILE A 824	None CA  A 301 (-4.9A) None None	0.67A	NA	19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1r7j	CONSERVED HYPOTHETICAL PROTEIN SSO10A (Sulfolobus solfataricus)	HTH_45	4	LEU A 14 - LEU A 765 ALA A 12 - ALA A 767 ILE A 13 - ILE A 768 ILE A 49 - ILE A 824	None	0.67A	NA	16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3rl5	METALLOPHOSPHOESTERASE MPPED2 (Rattus norvegicus)	Metallophos	4	LEU A 162 - LEU A 765 ALA A 177 - ALA A 767 ILE A 114 - ILE A 768 ILE A 112 - ILE A 824	None	0.67A	NA	21.95
	Hit	Macromolecule/ Organism	Pfam	Res.	Residue Matches	HETATM Residue/s	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock

[["1TBF_A_VIAA501_1","1tbf","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",6,"LEU A 725-LEU A 725;LEU A 765-LEU A 765;ALA A 767-ALA A 767;ILE A 768-ILE A 768;PHE A 820-PHE A 820;ILE A 824-ILE A 824","None;VIA A 501 ( 4.8A);VIA A 501 ( 4.0A);None;VIA A 501 (-3.7A);None","0.00A","57.9","100.00"],["1TBF_A_VIAA501_1","5jo3","Homo sapiens","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",6,"LEU B 725-LEU A 725;LEU B 765-LEU A 765;ALA B 767-ALA A 767;ILE B 768-ILE A 768;PHE B 820-PHE A 820;ILE B 824-ILE A 824","None;6LK B 903 (-4.5A);6LK B 903 (-3.5A);6LK B 903 (-4.2A);6LK B 903 (-3.4A);None","0.56A","54.3","99.69"],["1TBF_A_VIAA501_1","3ksm","Hahella chejuensis","ABC-TYPE SUGAR TRANSPORT SYSTEM, PERIPLASMIC COMPONENT","Peripla_BP_4",5,"LEU A 264-LEU A 725;ALA A 243-ALA A 767;ILE A 244-ILE A 768;PHE A 255-PHE A 820;ILE A 273-ILE A 824","None","0.82A","NA","22.93"],["1TBF_A_VIAA501_1","1bu8","Rattus norvegicus","PROTEIN (PANCREATIC LIPASE RELATED PROTEIN 2)","Lipase;PLAT",5,"LEU A 131-LEU A 765;ALA A 129-ALA A 767;ILE A 128-ILE A 768;PHE A 72-PHE A 820;ILE A 102-ILE A 824","None","0.87A","NA","21.70"],["1TBF_A_VIAA501_1","6ac8","Mycobacterium smegmatis mc2 155","MYCOBACTERIUM SMEGMATIS MFD","CarD_CdnL_TRCF;DEAD;Helicase_C;TRCF;UvrB_inter",5,"LEU A 481-LEU A 725;LEU A 16-LEU A 765;ALA A 14-ALA A 767;ILE A 13-ILE A 768;ILE A 483-ILE A 824","None;None;SO4 A1306 (-4.5A);None;None","0.94A","NA","14.85"],["1TBF_A_VIAA501_1","3kv0","Podospora anserina","HET-C2","GLTP",5,"LEU A 107-LEU A 725;LEU A 197-LEU A 765;ILE A 193-ILE A 768;PHE A 41-PHE A 820;ILE A 88-ILE A 824","None;MLY A 198 ( 4.3A);MLY A 192 ( 4.3A);None;None","0.94A","NA","23.85"],["1TBF_A_VIAA501_1","3sxx","Pichia angusta","PEROXISOMAL PRIMARY AMINE OXIDASE","Cu_amine_oxid;Cu_amine_oxidN2;Cu_amine_oxidN3",5,"LEU A 643-LEU A 765;ALA A 418-ALA A 767;ILE A 419-ILE A 768;PHE A 293-PHE A 820;ILE A 464-ILE A 824","None","0.94A","NA","18.30"],["1TBF_A_VIAA501_1","4xai","Escherichia coli o157:h7;tribolium castaneum;synthetic construct","MALTOSE-BINDING PERIPLASMIC PROTEIN,TAILLESS ORTHOLOG","SBP_bac_1",5,"LEU A1292-LEU A 725;LEU A1300-LEU A 765;ALA A1302-ALA A 767;ILE A1303-ILE A 768;ILE A1358-ILE A 824","None","0.96A","NA","22.98"],["1TBF_A_VIAA501_1","4udq","Methylovorus sp. mp688","GLUCOSE-METHANOL-CHOLINE OXIDOREDUCTASE","GMC_oxred_C;GMC_oxred_N",5,"LEU A 458-LEU A 725;LEU A 410-LEU A 765;ILE A 413-ILE A 768;PHE A 368-PHE A 820;ILE A 310-ILE A 824","None","1.01A","NA","20.59"],["1TBF_A_VIAA501_1","1hc7","Thermus thermophilus","PROLYL-TRNA SYNTHETASE","HGTP_anticodon;ProRS-C_1;tRNA-synt_2b",5,"LEU A 285-LEU A 725;LEU A 185-LEU A 765;ALA A 183-ALA A 767;PHE A 265-PHE A 820;ILE A 50-ILE A 824","None","1.04A","NA","21.15"],["1TBF_A_VIAA501_1","3hjv","Vibrio cholerae","MALONYL COA-ACYL CARRIER PROTEIN TRANSACYLASE","Acyl_transf_1",5,"LEU A 118-LEU A 725;ALA A 251-ALA A 767;ILE A 248-ILE A 768;PHE A 226-PHE A 820;ILE A 110-ILE A 824","None","1.09A","NA","20.33"],["1TBF_A_VIAA501_1","3nrg","Chloroflexus aurantiacus","TETR FAMILY TRANSCRIPTIONAL REGULATOR","TetR_N",5,"LEU A 174-LEU A 765;ALA A 179-ALA A 767;ILE A 175-ILE A 768;PHE A 102-PHE A 820;ILE A 98-ILE A 824","None","1.09A","NA","20.00"],["1TBF_A_VIAA501_1","2okc","Bacteroides thetaiotaomicron vpi-5482","TYPE I RESTRICTION ENZYME STYSJI M PROTEIN","HsdM_N;N6_Mtase",5,"LEU A 330-LEU A 725;LEU A 425-LEU A 765;ILE A 427-ILE A 768;PHE A 364-PHE A 820;ILE A 333-ILE A 824","None","1.11A","NA","22.15"],["1TBF_A_VIAA501_1","4b63","Aspergillus fumigatus","L-ORNITHINE N5 MONOOXYGENASE","K_oxygenase",5,"LEU A 31-LEU A 725;ALA A 53-ALA A 767;ILE A 54-ILE A 768;PHE A 81-PHE A 820;ILE A 79-ILE A 824","None","1.12A","NA","22.71"],["1TBF_A_VIAA501_1","4cj0","Clostridium thermocellum;synthetic construct","ENDOGLUCANASE D","CelD_N;Dockerin_1;Glyco_hydro_9",5,"LEU A 487-LEU A 765;ALA A 489-ALA A 767;ILE A 490-ILE A 768;PHE A 571-PHE A 820;ILE A 62-ILE A 824","None","1.12A","NA","20.09"],["1TBF_A_VIAA501_1","3si2","Mus musculus","GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE","Peptidase_M28",5,"LEU A 321-LEU A 725;LEU A 272-LEU A 765;ALA A 274-ALA A 767;ILE A 275-ILE A 768;ILE A 352-ILE A 824","None","1.22A","NA","22.16"],["1TBF_A_VIAA501_1","3nyi","Eubacterium ventriosum","FAT ACID-BINDING PROTEIN","DegV",5,"LEU A 152-LEU A 725;LEU A 131-LEU A 765;ILE A 132-ILE A 768;PHE A 87-PHE A 820;ILE A 119-ILE A 824","None","1.22A","NA","22.47"],["1TBF_A_VIAA501_1","3lyk","Haemophilus influenzae","STRINGENT STARVATION PROTEIN A HOMOLOG","GST_C",5,"LEU A 165-LEU A 725;LEU A 136-LEU A 765;ILE A 139-ILE A 768;PHE A 143-PHE A 820;ILE A 183-ILE A 824","None","1.23A","NA","20.23"],["1TBF_A_VIAA501_1","3b8a","Saccharomyces cerevisiae","HEXOKINASE-1","Hexokinase_1;Hexokinase_2",5,"LEU X 56-LEU A 725;ALA X 402-ALA A 767;ILE X 403-ILE A 768;PHE X 240-PHE A 820;ILE X 266-ILE A 824","None","1.27A","NA","22.13"],["1TBF_A_VIAA501_1","4nho","Homo sapiens","PROBABLE ATP-DEPENDENT RNA HELICASE DDX23","DEAD;Helicase_C",5,"LEU A 680-LEU A 725;LEU A 655-LEU A 765;ALA A 657-ALA A 767;ILE A 658-ILE A 768;ILE A 669-ILE A 824","None","1.28A","NA","20.83"],["1TBF_A_VIAA501_1","1nkg","Aspergillus aculeatus","RHAMNOGALACTURONASE B","CBM-like;RhgB_N;fn3_3",5,"LEU A 55-LEU A 725;LEU A 78-LEU A 765;ALA A 99-ALA A 767;ILE A 97-ILE A 768;ILE A 51-ILE A 824","None","1.29A","NA","18.81"],["1TBF_A_VIAA501_1","3rp8","Klebsiella pneumoniae","FLAVOPROTEIN MONOOXYGENASE","FAD_binding_3",5,"LEU A 207-LEU A 725;LEU A 252-LEU A 765;ALA A 254-ALA A 767;ILE A 253-ILE A 768;PHE A 219-PHE A 820","None","1.30A","NA","25.12"],["1TBF_A_VIAA501_1","3w0l","Xenopus laevis","GLUCOKINASE REGULATORY PROTEIN","NA",5,"LEU B 406-LEU A 725;LEU B 315-LEU A 765;ALA B 313-ALA A 767;ILE B 312-ILE A 768;ILE B 435-ILE A 824","None","1.35A","NA","22.12"],["1TBF_A_VIAA501_1","2bw3","Musca domestica","TRANSPOSASE","DBD_Tnp_Hermes;Dimer_Tnp_hAT",5,"LEU A 257-LEU A 725;LEU A 228-LEU A 765;ALA A 230-ALA A 767;ILE A 231-ILE A 768;ILE A 179-ILE A 824","None","1.37A","NA","21.64"],["1TBF_A_VIAA501_1","2zf8","Vibrio alginolyticus","COMPONENT OF SODIUM-DRIVEN POLAR FLAGELLAR MOTOR","MotY_N;OmpA",5,"LEU A 173-LEU A 725;LEU A 181-LEU A 765;ALA A 185-ALA A 767;ILE A 184-ILE A 768;ILE A 163-ILE A 824","None","1.37A","NA","22.13"],["1TBF_A_VIAA501_1","5i92","Pseudomonas aeruginosa","GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE","Aminotran_3",5,"LEU A 64-LEU A 765;ALA A 406-ALA A 767;ILE A 405-ILE A 768;PHE A 320-PHE A 820;ILE A 315-ILE A 824","None","1.38A","NA","21.65"],["1TBF_A_VIAA501_1","1fnn","Pyrobaculum aerophilum","CELL DIVISION CONTROL PROTEIN 6","AAA_22;Cdc6_C",5,"LEU A 282-LEU A 725;LEU A 293-LEU A 765;ALA A 295-ALA A 767;ILE A 296-ILE A 768;ILE A 346-ILE A 824","None","1.38A","NA","21.14"],["1TBF_A_VIAA501_1","2vz8","Sus scrofa","FATTY ACID SYNTHASE","ADH_zinc_N;Acyl_transf_1;KAsynt_C_assoc;KR;Ketoacyl-synt_C;Methyltransf_12;PP-binding;PS-DH;Thioesterase;ketoacyl-synt",5,"LEU A 404-LEU A 725;LEU A 341-LEU A 765;ALA A 339-ALA A 767;ILE A 342-ILE A 768;ILE A 6-ILE A 824","None","1.41A","NA","8.50"],["1TBF_A_VIAA501_1","1nu4","Homo sapiens","U1A RNA BINDING DOMAIN","RRM_1",5,"LEU A 17-LEU A 725;LEU A 30-LEU A 765;ALA A 32-ALA A 767;ILE A 33-ILE A 768;ILE A 14-ILE A 824","None","1.41A","NA","13.51"],["1TBF_A_VIAA501_1","4pkd","Sus scrofa;homo sapiens;synthetic construct","U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A,U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA","RRM_1",5,"LEU B 17-LEU A 725;LEU B 30-LEU A 765;ALA B 32-ALA A 767;ILE B 33-ILE A 768;ILE B 14-ILE A 824","None","1.43A","NA","18.72"],["1TBF_A_VIAA501_1","3w6j","Geobacillus stearothermophilus","SCPA","NA",5,"LEU A 21-LEU A 725;LEU A 69-LEU A 765;ALA A 71-ALA A 767;ILE A 72-ILE A 768;ILE A 40-ILE A 824","None","1.44A","NA","20.06"],["1TBF_A_VIAA501_1","5u00","Homo sapiens","CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE","PDEase_I",4,"LEU A 770-LEU A 725;LEU A 809-LEU A 765;PHE A 862-PHE A 820;ILE A 866-ILE A 824","None;7OV A1001 ( 4.6A);7OV A1001 (-3.9A);None","0.35A","44.3","36.09"],["1TBF_A_VIAA501_1","2dly","Mus musculus","FYN-RELATED KINASE","SH2",4,"LEU A 106-LEU A 725;LEU A 56-LEU A 765;ILE A 69-ILE A 768;PHE A 91-PHE A 820","None","0.44A","NA","15.03"],["1TBF_A_VIAA501_1","3i3w","Francisella tularensis subsp. tularensis","PHOSPHOGLUCOSAMINE MUTASE","PGM_PMM_I;PGM_PMM_II;PGM_PMM_III;PGM_PMM_IV",4,"LEU A 27-LEU A 725;LEU A 112-LEU A 765;PHE A 5-PHE A 820;ILE A 10-ILE A 824","None","0.45A","NA","20.40"],["1TBF_A_VIAA501_1","3hc7","Mycobacterium phage d29","GENE 12 PROTEIN","Cutinase",4,"LEU A 204-LEU A 725;ALA A 221-ALA A 767;ILE A 222-ILE A 768;ILE A 186-ILE A 824","None","0.46A","NA","20.72"],["1TBF_A_VIAA501_1","3dzd","Aquifex aeolicus","TRANSCRIPTIONAL REGULATOR (NTRC FAMILY)","Response_reg;Sigma54_activat",4,"LEU A 21-LEU A 765;ILE A 20-ILE A 768;PHE A 109-PHE A 820;ILE A 113-ILE A 824","None","0.49A","NA","22.83"],["1TBF_A_VIAA501_1","2v4u","Homo sapiens","CTP SYNTHASE 2","GATase",4,"LEU A 382-LEU A 765;ALA A 384-ALA A 767;ILE A 385-ILE A 768;ILE A 407-ILE A 824","None","0.49A","NA","25.41"],["1TBF_A_VIAA501_1","1co6","Blastochloris viridis","PROTEIN (CYTOCHROME C2)","Cytochrom_C",4,"LEU A 93-LEU A 765;ILE A 94-ILE A 768;PHE A 63-PHE A 820;ILE A 67-ILE A 824","None;None;HEC A 108 (-4.7A);None","0.51A","NA","14.38"],["1TBF_A_VIAA501_1","1wqu","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES\/FPS","SH2",4,"LEU A 103-LEU A 725;LEU A 51-LEU A 765;ILE A 64-ILE A 768;ILE A 85-ILE A 824","None","0.53A","NA","17.42"],["1TBF_A_VIAA501_1","4pkd","Sus scrofa;homo sapiens;synthetic construct","U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A,U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA","RRM_1",4,"LEU B 30-LEU A 765;ALA B 32-ALA A 767;ILE B 33-ILE A 768;PHE B 77-PHE A 820","None","0.54A","NA","18.72"],["1TBF_A_VIAA501_1","4eo9","Mycobacterium leprae","2,3-BISPHOSPHOGLYCERATE-DEPENDENT PHOSPHOGLYCERATE MUTASE","His_Phos_1",4,"LEU A 192-LEU A 725;LEU A 9-LEU A 765;ALA A 7-ALA A 767;ILE A 182-ILE A 824","None","0.56A","NA","21.75"],["1TBF_A_VIAA501_1","5v4s","Leptospira licerasiae serovar varillal str. var 010","TRANSPORTER, CATION CHANNEL FAMILY \/ CYCLIC NUCLEOTIDE-BINDING DOMAIN MULTI-DOMAIN PROTEIN","Ion_trans;cNMP_binding",4,"LEU A 133-LEU A 725;LEU A 151-LEU A 765;ALA A 153-ALA A 767;ILE A 129-ILE A 824","None","0.56A","NA","24.95"],["1TBF_A_VIAA501_1","4qhj","Methanocaldococcus jannaschii","UNCHARACTERIZED PROTEIN MJ1213","Peptidase_M56",4,"LEU A 7-LEU A 725;LEU A 55-LEU A 765;ILE A 54-ILE A 768;ILE A 63-ILE A 824","None","0.56A","NA","16.52"],["1TBF_A_VIAA501_1","5cuw","Streptomyces coelicolor (strain atcc baa-471 \/ a3(2) \/ m145)","SRTE1","Sortase",4,"LEU A 317-LEU A 725;LEU A 200-LEU A 765;ALA A 198-ALA A 767;ILE A 271-ILE A 824","None","0.57A","NA","20.54"],["1TBF_A_VIAA501_1","3qio","Human immunodeficiency virus type 1 group m subtype b;escherichia coli (strain k12);human immunodeficiency virus type 1 group m subtype b (isolate hxb2)","GAG-POL POLYPROTEIN,RIBONUCLEASE HI,GAG-POL POLYPROTEIN","RNase_H",4,"LEU A 479-LEU A 765;ALA A 481-ALA A 767;ILE A 482-ILE A 768;ILE A 505-ILE A 824","None","0.57A","NA","17.38"],["1TBF_A_VIAA501_1","4v2x","Bacillus halodurans","ENDO-BETA-1,4-GLUCANASE (CELLULASE B)","CBM46;CBM_X2;Cellulase",4,"LEU A 425-LEU A 765;ALA A 427-ALA A 767;ILE A 428-ILE A 768;ILE A 373-ILE A 824","None","0.58A","NA","23.57"],["1TBF_A_VIAA501_1","1sa3","Moraxella sp.;synthetic construct","TYPE II RESTRICTION ENZYME MSPI","Endonuc-MspI",4,"LEU A 48-LEU A 725;LEU A 67-LEU A 765;ALA A 69-ALA A 767;ILE A 77-ILE A 824","None","0.58A","NA","23.08"],["1TBF_A_VIAA501_1","3igh","Pyrococcus horikoshii","UNCHARACTERIZED METAL-DEPENDENT HYDROLASE","Amidohydro_3",4,"LEU X 138-LEU A 765;ALA X 140-ALA A 767;ILE X 141-ILE A 768;ILE X 147-ILE A 824","None","0.58A","NA","22.04"],["1TBF_A_VIAA501_1","4pv4","Yersinia pestis","PROLINE AMINOPEPTIDASE P II","AMP_N;Peptidase_M24",4,"LEU A 323-LEU A 725;LEU A 385-LEU A 765;ILE A 402-ILE A 768;ILE A 290-ILE A 824","None","0.58A","NA","22.66"],["1TBF_A_VIAA501_1","3cbl","Homo sapiens;synthetic construct","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES\/FPS","PK_Tyr_Ser-Thr;SH2",4,"LEU A 545-LEU A 725;LEU A 493-LEU A 765;ILE A 506-ILE A 768;ILE A 527-ILE A 824","None","0.58A","NA","20.81"],["1TBF_A_VIAA501_1","1ag9","Escherichia coli","FLAVODOXIN","Flavodoxin_1",4,"LEU A 52-LEU A 725;LEU A 73-LEU A 765;PHE A 78-PHE A 820;ILE A 109-ILE A 824","None","0.59A","NA","20.56"],["1TBF_A_VIAA501_1","5h5x","Streptomyces coelicolor (strain atcc baa-471 \/ a3(2) \/ m145)","PUTATIVE OXIDOREDUCTASE","adh_short_C2",4,"LEU A 140-LEU A 765;ALA A 142-ALA A 767;ILE A 143-ILE A 768;ILE A 195-ILE A 824","None","0.60A","NA","19.06"],["1TBF_A_VIAA501_1","1ci9","Burkholderia gladioli","PROTEIN (CARBOXYLESTERASE)","Beta-lactamase",4,"LEU A 302-LEU A 725;LEU A 96-LEU A 765;ALA A 98-ALA A 767;ILE A 121-ILE A 768","None","0.60A","NA","20.09"],["1TBF_A_VIAA501_1","1otk","Escherichia coli","PHENYLACETIC ACID DEGRADATION PROTEIN PAAC","NA",4,"LEU A 5-LEU A 725;LEU A 120-LEU A 765;ALA A 122-ALA A 767;ILE A 123-ILE A 768","None","0.60A","NA","20.79"],["1TBF_A_VIAA501_1","2v3z","Escherichia coli;synthetic construct","XAA-PRO AMINOPEPTIDASE","AMP_N;Peptidase_M24",4,"LEU A 325-LEU A 725;LEU A 386-LEU A 765;ILE A 403-ILE A 768;ILE A 292-ILE A 824","None","0.60A","NA","21.51"],["1TBF_A_VIAA501_1","3wqb","Aeromonas sobria","EXTRACELLULAR SERINE PROTEASE","P_proprotein;Peptidase_S8",4,"LEU A 365-LEU A 725;ALA A 136-ALA A 767;ILE A 135-ILE A 768;ILE A 417-ILE A 824","None","0.60A","NA","21.49"],["1TBF_A_VIAA501_1","3haz","Bradyrhizobium japonicum usda 110","PROLINE DEHYDROGENASE","Aldedh;Pro_dh;Pro_dh-DNA_bdg",4,"LEU A 904-LEU A 765;ALA A 906-ALA A 767;ILE A 907-ILE A 768;ILE A 929-ILE A 824","None","0.60A","NA","15.77"],["1TBF_A_VIAA501_1","5kaz","Homo sapiens","SH2 DOMAIN-CONTAINING PROTEIN 1B","SH2",4,"LEU A 97-LEU A 725;LEU A 42-LEU A 765;ILE A 55-ILE A 768;ILE A 83-ILE A 824","None","0.61A","NA","15.00"],["1TBF_A_VIAA501_1","4g1q","Human immunodeficiency virus type 1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","RVT_1;RVT_connect;RVT_thumb",4,"LEU A 479-LEU A 765;ALA A 481-ALA A 767;ILE A 482-ILE A 768;ILE A 505-ILE A 824","None","0.61A","NA","20.64"],["1TBF_A_VIAA501_1","3eo8","Clostridium difficile 630","BLUB-LIKE FLAVOPROTEIN","Nitroreductase",4,"LEU A 150-LEU A 765;ALA A 152-ALA A 767;ILE A 153-ILE A 768;ILE A 7-ILE A 824","None","0.61A","NA","19.54"],["1TBF_A_VIAA501_1","3dds","Homo sapiens","GLYCOGEN PHOSPHORYLASE, LIVER FORM","Phosphorylase",4,"LEU A 765-LEU A 725;LEU A 581-LEU A 765;ILE A 584-ILE A 768;ILE A 742-ILE A 824","None","0.61A","NA","17.65"],["1TBF_A_VIAA501_1","4c91","Bacteroides ovatus","ALPHA-GLUCURONIDASE GH115","GH115_C;Glyco_hydro_115",4,"LEU A 46-LEU A 725;LEU A 160-LEU A 765;ILE A 157-ILE A 768;ILE A 96-ILE A 824","None","0.61A","NA","15.99"],["1TBF_A_VIAA501_1","2erf","Homo sapiens","THROMBOSPONDIN-1","NA",4,"LEU A 130-LEU A 725;LEU A 149-LEU A 765;ALA A 147-ALA A 767;ILE A 138-ILE A 824","None","0.61A","NA","19.65"],["1TBF_A_VIAA501_1","2mca","Eubacterium rectale","UNCHARACTERIZED PROTEIN","DUF5300",4,"LEU A 13-LEU A 765;ILE A 45-ILE A 768;PHE A 47-PHE A 820;ILE A 11-ILE A 824","None","0.62A","NA","14.74"],["1TBF_A_VIAA501_1","5nny","Legionella pneumophila","WIPB","NA",4,"LEU A 137-LEU A 725;LEU A 44-LEU A 765;ILE A 43-ILE A 768;ILE A 113-ILE A 824","None","0.62A","NA","23.20"],["1TBF_A_VIAA501_1","3nvn","Ectromelia virus;homo sapiens","PLEXIN-C1","PSI",4,"LEU B 429-LEU A 725;LEU B 399-LEU A 765;ILE B 416-ILE A 768;ILE B 439-ILE A 824","None","0.62A","NA","20.95"],["1TBF_A_VIAA501_1","3m6i","Neurospora crassa","L-ARABINITOL 4-DEHYDROGENASE","ADH_N;ADH_zinc_N",4,"LEU A 330-LEU A 725;LEU A 197-LEU A 765;ALA A 199-ALA A 767;ILE A 223-ILE A 824","None","0.62A","NA","20.66"],["1TBF_A_VIAA501_1","2vif","Homo sapiens","SUPPRESSOR OF CYTOKINE SIGNALLING 6","SH2",4,"LEU A 487-LEU A 725;LEU A 420-LEU A 765;ILE A 433-ILE A 768;ILE A 458-ILE A 824","None","0.62A","NA","17.01"],["1TBF_A_VIAA501_1","5z2c","Homo sapiens","ALPHA-PROTEIN KINASE 1","NA",4,"LEU A 239-LEU A 725;LEU A 444-LEU A 765;ILE A 445-ILE A 768;ILE A 221-ILE A 824","None","0.62A","NA","21.78"],["1TBF_A_VIAA501_1","5tib","Escherichia coli;homo sapiens","SUGAR ABC TRANSPORTER SUBSTRATE-BINDING PROTEIN,GASDERMIN-B","Gasdermin_C",4,"LEU A1279-LEU A 725;LEU A1399-LEU A 765;ILE A1398-ILE A 768;PHE A1332-PHE A 820","None","0.62A","NA","22.05"],["1TBF_A_VIAA501_1","3pi7","Mesorhizobium loti","NADH OXIDOREDUCTASE","ADH_N;ADH_zinc_N",4,"LEU A 150-LEU A 765;ALA A 152-ALA A 767;ILE A 153-ILE A 768;ILE A 304-ILE A 824","None","0.62A","NA","21.39"],["1TBF_A_VIAA501_1","1gnt","Desulfovibrio vulgaris","HYBRID CLUSTER PROTEIN","Prismane",4,"LEU A 183-LEU A 725;LEU A 66-LEU A 765;ALA A 68-ALA A 767;ILE A 152-ILE A 824","None","0.63A","NA","23.05"],["1TBF_A_VIAA501_1","3sp1","Borrelia burgdorferi","CYSTEINYL-TRNA SYNTHETASE","tRNA-synt_1e",4,"LEU A 5-LEU A 725;LEU A 49-LEU A 765;ILE A 50-ILE A 768;ILE A 235-ILE A 824","None","0.63A","NA","23.31"],["1TBF_A_VIAA501_1","2wzp","Lactococcus phage p2;lama glama","LACTOCOCCAL PHAGE P2 ORF16","Caudo_bapla16",4,"ALA R 176-ALA A 767;ILE R 179-ILE A 768;PHE R 157-PHE A 820;ILE R 156-ILE A 824","None","0.63A","NA","22.14"],["1TBF_A_VIAA501_1","4zcf","Escherichia coli;synthetic construct","RESTRICTION ENDONUCLEASE ECOP15I, RESTRICTION SUBUNIT","RE_endonuc;ResIII",4,"LEU C 132-LEU A 725;LEU C 144-LEU A 765;ILE C 181-ILE A 768;PHE C 99-PHE A 820","None","0.64A","NA","16.29"],["1TBF_A_VIAA501_1","3bge","Haemophilus influenzae","PREDICTED ATPASE","MgsA_C",4,"LEU A 294-LEU A 765;ALA A 296-ALA A 767;ILE A 297-ILE A 768;ILE A 336-ILE A 824","None","0.64A","NA","19.03"],["1TBF_A_VIAA501_1","1f5n","Homo sapiens","INTERFERON-INDUCED GUANYLATE-BINDING PROTEIN 1","GBP;GBP_C",4,"LEU A 13-LEU A 725;LEU A 31-LEU A 765;ALA A 33-ALA A 767;ILE A 34-ILE A 768","None","0.64A","NA","20.10"],["1TBF_A_VIAA501_1","1nc7","Thermotoga maritima","HYPOTHETICAL PROTEIN TM1070","ASRT",4,"LEU A 68-LEU A 765;ILE A 73-ILE A 768;PHE A 44-PHE A 820;ILE A 81-ILE A 824","None","0.64A","NA","20.55"],["1TBF_A_VIAA501_1","3qok","Klebsiella pneumoniae subsp. pneumoniae","PUTATIVE CHITINASE II","Glyco_hydro_18",4,"LEU A 84-LEU A 725;LEU A 109-LEU A 765;ILE A 148-ILE A 768;ILE A 139-ILE A 824","None","0.64A","NA","23.97"],["1TBF_A_VIAA501_1","1nu4","Homo sapiens","U1A RNA BINDING DOMAIN","RRM_1",4,"LEU A 30-LEU A 765;ALA A 32-ALA A 767;ILE A 33-ILE A 768;PHE A 77-PHE A 820","None","0.64A","NA","13.51"],["1TBF_A_VIAA501_1","5kvk","Klebsiella pneumoniae 700603","PROTEIN KP700603","CinA",4,"LEU A 162-LEU A 725;LEU A 23-LEU A 765;ALA A 25-ALA A 767;ILE A 104-ILE A 824","None","0.64A","NA","18.05"],["1TBF_A_VIAA501_1","3dxq","Mesorhizobium loti","CHOLINE\/ETHANOLAMINE KINASE FAMILY PROTEIN","Choline_kinase",4,"LEU A 23-LEU A 725;LEU A 10-LEU A 765;ALA A 12-ALA A 767;ILE A 13-ILE A 768","None","0.64A","NA","21.28"],["1TBF_A_VIAA501_1","4hku","Listeria monocytogenes","TETR TRANSCRIPTIONAL REGULATOR","TetR_C_27;TetR_N",4,"LEU A 125-LEU A 765;ALA A 123-ALA A 767;PHE A 68-PHE A 820;ILE A 67-ILE A 824","None","0.64A","NA","20.83"],["1TBF_A_VIAA501_1","3kts","Listeria monocytogenes str. 4b","GLYCEROL UPTAKE OPERON ANTITERMINATOR REGULATORY PROTEIN","NA",4,"LEU A 41-LEU A 725;LEU A 57-LEU A 765;ILE A 84-ILE A 768;ILE A 79-ILE A 824","None","0.64A","NA","21.33"],["1TBF_A_VIAA501_1","5ima","Xanthomonas campestris pv. campestris (strain atcc 33913 \/ dsm 3586 \/ ncppb 528 \/ lmg 568 \/ p 25)","BACTERIOFERRITIN COMIGRATORY PROTEIN","AhpC-TSA",4,"LEU A 101-LEU A 725;LEU A 27-LEU A 765;ALA A 29-ALA A 767;ILE A 37-ILE A 824","None","0.65A","NA","18.52"],["1TBF_A_VIAA501_1","2afw","Homo sapiens","GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE","Peptidase_M28",4,"LEU A 318-LEU A 725;LEU A 271-LEU A 765;ALA A 273-ALA A 767;ILE A 274-ILE A 768","None","0.65A","NA","22.49"],["1TBF_A_VIAA501_1","4g6c","Burkholderia cenocepacia","BETA-HEXOSAMINIDASE 1","Glyco_hydro_3",4,"LEU A 197-LEU A 765;ALA A 195-ALA A 767;ILE A 196-ILE A 768;ILE A 239-ILE A 824","None","0.65A","NA","23.44"],["1TBF_A_VIAA501_1","3pih","Thermotoga maritima;synthetic construct","UVRABC SYSTEM PROTEIN A","ABC_tran;UvrA_DNA-bind;UvrA_inter",4,"LEU A 635-LEU A 725;LEU A 590-LEU A 765;ALA A 588-ALA A 767;ILE A 652-ILE A 824","None","0.65A","NA","16.68"],["1TBF_A_VIAA501_1","5ew8","Homo sapiens","FIBROBLAST GROWTH FACTOR RECEPTOR 1","PK_Tyr_Ser-Thr",4,"LEU A 465-LEU A 725;LEU A 525-LEU A 765;ALA A 520-ALA A 767;ILE A 529-ILE A 824","None","0.65A","NA","20.16"],["1TBF_A_VIAA501_1","2qq8","Homo sapiens","TBC1 DOMAIN FAMILY MEMBER 14","RabGAP-TBC",4,"LEU A 504-LEU A 765;ILE A 503-ILE A 768;PHE A 465-PHE A 820;ILE A 464-ILE A 824","None","0.65A","NA","26.35"],["1TBF_A_VIAA501_1","1xkn","Chlorobium tepidum","PUTATIVE PEPTIDYL-ARGININE DEIMINASE","PAD_porph",4,"LEU A 155-LEU A 725;LEU A 193-LEU A 765;ILE A 199-ILE A 768;ILE A 160-ILE A 824","None","0.65A","NA","22.60"],["1TBF_A_VIAA501_1","2d4a","Aeropyrum pernix","MALATE DEHYDROGENASE","Ldh_1_C;Ldh_1_N",4,"LEU B 18-LEU A 725;ALA B 235-ALA A 767;ILE B 236-ILE A 768;ILE B 2-ILE A 824","None","0.65A","NA","22.07"],["1TBF_A_VIAA501_1","4k5s","Streptomyces argillaceus","OXYGENASE","FAD_binding_3",4,"LEU A 309-LEU A 725;LEU A 117-LEU A 765;ALA A 115-ALA A 767;PHE A 73-PHE A 820","None","0.65A","NA","20.51"],["1TBF_A_VIAA501_1","3mru","Vibrio alginolyticus","AMINOACYL-HISTIDINE DIPEPTIDASE","M20_dimer;Peptidase_M20",4,"LEU A 77-LEU A 725;LEU A 483-LEU A 765;ALA A 485-ALA A 767;ILE A 141-ILE A 824","None","0.66A","NA","21.56"],["1TBF_A_VIAA501_1","5e31","Enterococcus faecium do","PENICILLIN BINDING PROTEIN 2 PRIME","MecA_N;PBP_dimer;Transpeptidase",4,"LEU A 274-LEU A 725;LEU A 568-LEU A 765;ALA A 570-ALA A 767;ILE A 569-ILE A 768","None","0.66A","NA","20.34"],["1TBF_A_VIAA501_1","4y4q","Streptococcus pneumoniae pcs8235","SORTASE, SRTB FAMILY","Sortase",4,"LEU A 238-LEU A 765;ALA A 254-ALA A 767;ILE A 236-ILE A 768;ILE A 127-ILE A 824","None","0.66A","NA","20.96"],["1TBF_A_VIAA501_1","3zvk","Rickettsia felis;synthetic construct","TOXIN OF TOXIN-ANTITOXIN SYSTEM","PIN",4,"LEU A 25-LEU A 725;LEU A 5-LEU A 765;ILE A 36-ILE A 768;ILE A 34-ILE A 824","None","0.67A","NA","16.18"],["1TBF_A_VIAA501_1","5yjd","Staphylococcus epidermidis rp62a","CSM3","RAMPs",4,"LEU A 96-LEU A 725;ILE A 199-ILE A 768;PHE A 166-PHE A 820;ILE A 169-ILE A 824","None; CA A 301 (-4.9A);None;None","0.67A","NA","19.94"],["1TBF_A_VIAA501_1","1r7j","Sulfolobus solfataricus","CONSERVED HYPOTHETICAL PROTEIN SSO10A","HTH_45",4,"LEU A 14-LEU A 765;ALA A 12-ALA A 767;ILE A 13-ILE A 768;ILE A 49-ILE A 824","None","0.67A","NA","16.50"],["1TBF_A_VIAA501_1","3rl5","Rattus norvegicus","METALLOPHOSPHOESTERASE MPPED2","Metallophos",4,"LEU A 162-LEU A 765;ALA A 177-ALA A 767;ILE A 114-ILE A 768;ILE A 112-ILE A 824","None","0.67A","NA","21.95"]]